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Investigating the role of O-GlcNAcylation in regulating 
synaptic and cognitive decline with age 
 
Elizabeth G. Wheatley 
 
Abstract 
Cognitive decline is emblematic of brain aging, ascribed in large part to age-related 
changes occurring at neuronal synapses. Dynamic post-translational protein 
modifications – in particular phosphorylation and O-GlcNAcylation – are known 
regulators of synaptic and cognitive function. However, how the landscape of synaptic 
PTMs changes with age has yet to be elucidated. In this study, age-dependent changes 
in phosphorylation and O-GlcNAcylation were characterized using a proteomics-based 
approach. Analyses implicate age-dependent changes in dynamic PTMs in age-related 
cognitive decline and vulnerability to neurodegenerative disorders, including 
Parkinson’s and Alzheimer’s disease. The functional relevance of age-related changes 
in PTMs, in particular of O-GlcNAcylation, was also investigated in vivo. Mimicking age-
related decreased levels of neuronal O-GlcNAc recapitulated features of molecular, 
synaptic, and cognitive aging in mice, implicating that changes in O-GlcNAc promote 
brain dysfunction during aging. Moreover, increasing O-GlcNAcylation in the adult 
hippocampus enhanced cognition, proposing O-GlcNAc as a target for brain 
rejuvenation. Ultimately, this study proposes dynamic PTMs as novel molecular drivers 
of brain aging, and provides the foundation for future mechanistic studies to investigate 
site-specific molecular changes underlying synaptic and cognitive decline with age.  
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Abstract 
Aging elicits significant cognitive impairments governed by the brain region known as 
the hippocampus. The hippocampus is one of the most extensively characterized 
regions in the context of aging, due to the presence of stereotypic alterations that occur 
with age. In this study, molecular, synaptic, and cognitive aspects of hippocampal aging 
are characterized, in order to demonstrate the facilities, animals, and materials used 
within the larger scope of this project are suited to characterize the progression or 
reversal of hallmarks of brain aging.   
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Introduction 
Cognitive impairment is one of the most widespread hallmarks of human aging. Adults 
over 65 are now the fastest growing age group [1], and as such, it comes as no surprise 
that incidences of aging-associated impairments have increased dramatically in recent 
years. While severe forms of cognitive dysfunction like dementia commonly arise due to 
the onset of neurodegenerative disorders like Alzheimer’s disease (AD), many healthy 
aging individuals still experience impairments in higher-order cognitive functions [2-4]. 
Among the most common are impairments in spatial and contextual memory, which are 
governed by a brain region called the hippocampus. Recent work in the scientific 
community has demonstrated that latent plasticity in the aged mammalian hippocampus 
can be targeted to reverse cognitive impairments, proposing that brain rejuvenation may 
be achievable in aging humans [5, 6]. In order to restore cognitive integrity in the 
elderly, however, it is necessary to further elucidate how the mechanisms that regulate 
cognition are altered during aging to promote impairments.   
 The use of model organisms has proven invaluable in the pursuit of mechanisms 
that regulate learning and memory. In the context of aging, cognitive impairments are 
conserved across species- ranging from rodents, to non-human primates, to humans. 
The rodent in particular is utilized extensively for investigating aging of the mammalian 
hippocampus, due to its adequately sophisticated brain and modest 2-year lifespan. 
Both the rat and mouse display impaired spatial learning and memory via the Morris and 
radial arm water mazes [7-9], and Barnes maze [10], and impaired contextual memory 
via the fear conditioning paradigm [11, 12]. In support of the relevance of these 
behavioral paradigms, elderly humans display impaired spatial learning and memory in 
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a virtual-reality based Morris water maze that is analogous to those observed in rodents 
when compared to young controls [13]. The mammalian hippocampus is a highly 
attractive platform for investigating the cellular and molecular mechanisms that govern 
aging and rejuvenation, given it displays such stereotypic impairments in cognition that 
are conserved between species.  
 
Aging and the mammalian hippocampus  
The hippocampus is a complex structure composed of functionally distinct subregions: 
the dentate gyrus (DG), CA1, CA2, CA3 and subiculum (Figure 1). Information 
processing in the hippocampus occurs through a mostly unidirectional pathway, via the 
tri-synaptic neuronal circuit. Projections from neurons in the entorhinal cortex (EC) 
connect to the DG via the perforant path, which in turn give rise to projections called 
mossy fibers, terminating within the DG and CA3. Fibers projecting from CA3, called 
Schaffer collateral projections, innervate the CA1, and the CA1 outputs to the subiculum 
and the EC [14]. The primary excitatory neurons within the DG and CA1/CA3 are 
granule cells and pyramidal cells, respectively, and their activity is tightly regulated by a 
heterogeneous population of inhibitory neurons. Hippocampal neurons also interact with 
glia cells, microglia (the resident macrophages of the brain) and the neurovasculature, 
resulting in a complex bi-directional regulation of cellular functionality.  
The hippocampus as whole is a particularly sensitive brain region to the effects of 
aging. Although it was initially believed that age-related impairments in cognition were 
caused by widespread cell death, particularly the death of neurons, modern advances in 
post-mortem tissue processing have clarified there is no significant cell loss in the   
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Figure 1. Hallmarks of hippocampal aging. Schematic illustration depicting 
alterations in cellular, functional and cognitive processes that occur with increased age 
in the adult hippocampal brain region. Cellular changes include decreased synaptic 
spine density on mature neurons, and increased microglial activation, resulting in 
impaired excitatory neuronal function and decreased cognitive capabilities, such as 
capacity for spatial learning and memory. Hippocampal sub-regions depicted are the 
CA1, CA3, dentate gyrus (DG), and entorhinal cortex (EC). Functional schematic 
depicts population spike amplitude (PSA) from electrophysiological recordings, and 
cognitive task depicted is the radial arm water maze. Schematic is adapted from Fan et 
al., Annu Rev Neurosci, 2017 Jul 25;40:251-272.  
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hippocampus of humans, non-human primates, or rodents [15, 16]. Despite this 
preservation of cell number, aging elicits significant changes in the structure and 
function of different cell types, especially neurons. Age-related structural changes are 
somewhat subtle in hippocampal neurons, and are primarily localized to neuronal 
synapses [17, 18]. In particular, aging elicits changes in synaptic composition, reduced 
synaptic density, and impaired synaptic plasticity [19-21]- the activity-dependent change 
in the strength of synaptic connections between neurons. Alongside these cellular 
changes, electrophysiological recordings performed on excitatory neurons in the 
hippocampal circuitry reveal a reliable decline in excitatory synaptic function with age 
[22, 23]. Collectively, these cellular alterations and synaptic impairments manifest as 
declines in hippocampal-dependent cognition, such as impaired performance in a 
spatial memory task (summarized in Figure 1).  
 Although hallmarks of hippocampal aging have been well established by the field, 
the progression of cellular and cognitive phenotypes is impacted by variables such as 
rodent background strain, housing, diet, enrichment, and behavioral facility. It is of 
significant importance therefore to validate the development of stereotypic cellular and 
cognitive changes in the context of a cognitive aging study.  
 
Results 
In order to establish a valid reference point for characterizing hallmarks of 
hippocampal aging, molecular, structural, and cognitive changes were characterized 
in young (3 month old) and aged (18-20 month old) wild type C57BL/6 mice.  
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The gross architecture of the aging hippocampus was profiled using a Cresyl violet 
stain for Nissl bodies, which are granules of rough endoplasmic reticulum enriched in 
neurons. The mean intensity of Nissl body staining was measured as a gauge for 
widespread changes in neuronal cell number. Consistent with previous reports, no 
widespread cell loss was observed in the CA1 or DG sub-regions in aged versus young 
hippocampal sections (Figure 2A,B). Neuronal molecular hallmarks were then 
characterized using diaminobenzadine (DAB) immunohistochemical staining. 
Phosphorylation of the transcription factor Creb at site Ser133 (pCreb) promotes 
immediate early gene (IEG) expression, synaptic plasticity, and learning and memory 
[24]. Mean intensity of neuronal pCreb was quantified in young and aged hippocampal 
brain sections (Figure 2C,D). In addition, cFos, an IEG downstream of pCreb and a 
marker of neuronal activity [25], was characterized as well (Figure 2E,F). Consistent with 
independent reports of hippocampal aging [5, 6], neuronal pCreb and cFos-positive 
neurons both declined with age in the CA1 and DG sub-regions (Figure 2C-F).  
Neuronal structural changes were then profiled using a Golgi stain, which labels 
the entire cell body, processes, and synaptic structures of individual sparsely distributed 
neurons. The post-synaptic structural components of neurons, called dendritic spines, 
can be readily quantified using Golgi staining. The density of tertiary dendritic spines 
(spines per µm) was quantified on both CA1 pyramidal and DG granular neurons, and an 
age-dependent decrease in neuronal spine density was observed in both hippocampal 
sub-regions (Figure 3A,B).  
Lastly, in a larger cohort of young and aged mice, two forms of hippocampal- 
dependent cognition were characterized. Spatial learning and memory was assessed by  
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Figure 2. Hippocampal aging elicits a decline in neuronal activity but no 
widespread cell loss. (A) Representative field of Nissl stain in the hippocampus of 
young (3 month old) and aged (18 month old) mice, with quantification of mean intensity 
in DG and CA1 regions shown in (B). (C) Representative field of pCreb immunostain in 
young and aged mice with quantification of mean intensity in DG and CA1 regions 
shown in (D). (E) Representative field of cFos immunostain in young and aged mice 
with quantification of cFos-positive cells in the DG or CA1 region shown in (F). Data 
represented as mean ± SEM *P<0.05; **P<0.01; t-test (B,D,F). Scale bars = 200 µm, n 
= 3 mice per group.  
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the radial arm water maze (RAWM) (Figure 4A,B), and contextual memory was assessed 
using the fear-conditioning paradigm (Figure 4F).  Results from RAWM revealed that 
while young and aged mice are able to learn the task at a similar rate during the training 
phase (Figure 4C), aged mice exhibit a modest impairment in short-term spatial memory 
(Figure 4D), and significant impairments in longer-term spatial memory (Figure 4C,E).  
Results from the fear conditioning behavioral paradigm revealed that while young and 
aged mice exhibit no differences in baseline freezing, aged mice freeze less during the 
contextual testing phase, confirming an impairment in hippocampal memory (Figure 4G). 
Additionally, no difference was observed in cued freezing behavior between young and 
aged mice (Figure 4G). Cued fear memory is more strongly dependent on a brain region 
called the amygdala, which is less sensitive to the effects of aging [11, 17].  
 
Discussion 
Characteristic hallmarks of aging were profiled in cohorts of young and aged wild type 
mice in-house, in order to elucidate the timeframe under which housing and handling 
would permit aging-related impairments. Consistent with previous reports, aging did not 
drive significant neuronal cell loss in the hippocampus, but did elicit reduced pCreb and 
c-Fos expression, two molecular changes associated with impaired synaptic plasticity. 
Consistent with this finding, aging elicited a reduction in dendritic spine density in CA1 
pyramidal and DG granular neurons of the hippocampus, suggesting fewer synaptic 
connections exist in the circuitry of the aged hippocampus. Synaptic signaling is 
essential for regulating learning and memory, and impairments in plasticity and structure  
are highly suggestive of cognitive impairments. Indeed, aged mice demonstrated  
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Figure 3. Aging elicits a reduction in hippocampal neuron dendritic spine density. 
(A) Representative field of Golgi stain from DG granule cell neurons and CA1 pyramidal 
neurons in young (3 month old) versus aged (24 month old) mice. (B) Quantification of 
spine number from tertiary dendrites of DG granule cell neurons or CA1 pyramidal 
neurons in young or aged mice; 4 neurons were quantified per sub-region, per mouse; n 
= 4 mice per group. Data represented as mean ± SEM *P<0.05; **P<0.01; t-test. 
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Figure 4. Aging elicits impairments in hippocampal-dependent spatial and 
contextual memory. (A) Hippocampal-dependent learning and memory was assessed 
in young (3 month old) and aged (18–20 month old) mice using two independent 
paradigms. (B) Radial arm water maze (RAWM) was used to assess spatial learning 
and memory. (C-E) Quantification of the number of entry errors during RAWM training 
and testing, (D) short-term memory testing, and (E) long-term learning and memory 
testing. (F) Fear conditioning was used to assess contextual fear memory. (G) Baseline, 
hippocampal-dependent contextual, and amygdala-dependent cued freezing behavior 
was quantified in young and aged mice using FreezeScan software. n = 8 mice per 
group. Data represented as mean ± SEM; *P<0.05; **P<0.01; ***P<0.001; repeated 
measures ANOVA, Bonferroni post-hoc test (C); t-test (D,E,G).   
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impairments, specifically in hippocampal-dependent spatial and contextual memory 
when compared to young controls. Collectively, these data establish a reference point 
for hippocampal aging and support the validity of the techniques and paradigms utilized 
within the present studies.  
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Materials and Methods 
 
Animal Models. All mouse handling and use was in accordance with institutional and 
ethical guidelines approved by the University of California San Francisco IACUC. The 
following mouse lines were used: C57BL/6 young mice (The Jackson Laboratory), 
C57BL/6 young and aged mice (National Institutes of Aging; Taconic Biosciences). All 
studies were done in male mice. The numbers of mice used to result in statistically 
significant differences were calculated using standard power calculations with α = 0.05 
and a power of 0.8. We used an online tool 
(http://www.stat.uiowa.edu/~rlenth/Power/index.html) to calculate power and samples 
size based on experience with the respective tests, variability of the assays and inter-
individual differences within groups. Mice were housed under specific pathogen-free 
conditions under a 12 h light-dark cycle. All experiments were randomized and blinded 
by an independent researcher. Researchers remained blinded throughout histological, 
molecular, and behavioral assessments. Groups were un-blinded at the end of each 
experiment upon statistical analysis. 
 
Nissl Staining. Sections were cut to 40µm and mounted on superfrost plus microscope 
slides (ThermoFisher) and allowed to dry overnight. Slides were then soaked in 100% 
ethanol 3x2min each, and then immersed in cresyl violet working solution for 10 min. 
Slides were then dipped in 95% ethanol, soaked in 100% ethanol 2x2min, then in 
Citrasolv 2x2min before being cover slipped with Entellan. Mean intensity was 
quantified using FIJI software (Version 1.0). 
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Immunohistochemistry. Tissue processing and immunohistochemistry was performed 
on free-floating sections following standard published techniques [26]. Mice were 
anesthetized with ketamine, transcardially perfused with 0.9% saline, and brains 
removed and fixed in phosphate-buffered 4% paraformaldehyde for 48h before 
cryoprotection with 30% sucrose. Free floating coronal sections (40 µm) were incubated 
overnight with either rabbit anti-phospho-Creb (Ser133) (1:2,500; CST) or rabbit anti-c-
Fos (Ab-5) (4-17) (1:10,000; Calbiochem) primary antibodies, and staining was revealed 
using biotinylated secondary antibodies and the ABC kit (Vector) with Diaminobenzidine 
(DAB, Sigma-Aldrich). Sections were mounted in phosphate buffer on superfrost plus 
microscope slides (ThermoFisher), allowed to dry overnight, briefly soaked in Citrasolv 
and cover slipped with Entellan. Mean intensity for phospho-Creb and individual cell 
number for c-Fos were quantified using FIJI software (Version 1.0). 
 
Golgi Staining. After brain removal, hemispheres were immersed in 10 ml of A+B 
solution from FD Rapid GolgiStain™ Kit, which was prepared 24 hours prior. Solution 
was then changed after the initial 12 hours, and left for 10 days at room temperature in 
the dark. Brains were then transferred to solution C, which was changed after the initial 
24 hours, and then left for 3 days at room temperature in the dark. Brains were cut into 
100 µm sections using a vibratome and were mounted onto slides coated with 0.3% 
gelatin in solution C. Slides were then air-dried for 24 hours in the dark. Slides were 
immersed into Milli-Q H2O, 2 x 4 min with gentle shaking, then transferred to a 
developing solution (Solution D, E, and Milli-Q H2O) for 10 min. Slides were then rinsed 
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2x4 min in Milli-Q H2O, dehydrated through graded ethanol, immersed in Xylenes 3x4 
min, and then coverslipped using Permount. All slides were then blinded and neurons 
imaged using a 63X oil immersion objective. Tertiary dendritic spine density was 
quantified using FIJI software (Version 1.0) for dendritic tracing and spine count, and 
results were un-blinded just prior to statistical analyses.  
 
Radial Arm Water Maze. Paradigm followed previously described protocol [27]. The 
goal arm location containing a platform remains constant throughout the training and 
testing phase, while the start arm is changed during each trial. Entry into an incorrect 
arm is scored as an error, and errors are averaged over training blocks (three 
consecutive trials). On day one during the training phase, mice are trained for 15 trials, 
with trials alternating between a visible and hidden platform. Every 3 trials are counted 
as one block of training. Prior to the final 3 trials of day 1 (block 5), the mice are given 
an extended break, and short-term memory is then tested using three consecutive 
hidden platform trials. On subsequent days during the testing phase, mice are tested for 
15 trials per day with a hidden platform. All behavior is performed double blinded.  
 
Contextual Fear Conditioning. Paradigm follows previously published techniques [28]. 
Mice learned to associate the environmental context (fear conditioning chamber) with an 
aversive stimulus (mild foot shock; unconditioned stimulus, US) enabling testing for 
hippocampal-dependent contextual fear conditioning. The mild foot shock was paired 
with a light and tone cue (conditioned stimulus, CS) in order to also assess amygdala- 
dependent cued fear conditioning. Conditioned fear was displayed as freezing behavior. 
! 16!
Specific training parameters are as follows: tone duration is 30 seconds; level is 70 dB, 
2 kHz; shock duration is 2 seconds; intensity is 0.6 mA. On day 1 each mouse was 
placed in a fear-conditioning chamber and allowed to explore for 2 minutes before 
delivery of a 30-second tone (70 dB) ending with a 2-second foot shock (0.6mA). Two 
minutes later, a second CS-US pair was delivered. On day 2 each mouse was first 
place in the fear- conditioning chamber containing the same exact context, but with no 
administration of a CS or foot shock. Freezing was analyzed for 1-3 minutes. One hour 
later, the mice were placed in a new context containing a different odor, cleaning 
solution, floor texture, chamber walls and shape. Animals were allowed to explore for 2 
minutes before being re-exposed to the CS. Freezing was analyzed for 1-3 minutes. 
Freezing was measured using a FreezeScan video tracking system and software 
(Cleversys, Inc). All behavior is performed double blinded.  
 
Data and statistical analysis. Graphed data are expressed as mean ± SEM. Statistical 
analysis was performed with Prism 5.0 software (GraphPad Software). Means between 
two groups were compared with two-tailed, unpaired Student’s t-test. Comparisons of 
means from multiple groups with each other or against one control group were analyzed 
with 2-way ANOVA and Bonferroni post hoc tests. All histology, electrophysiology and 
behavior experiments conducted were done in a randomized and blinded fashion. For 
each experiment, the overall size of the experimental groups corresponded to distinct 
animals. Unique samples were not measured repeatedly within the same 
characterization of a given cohort.  
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Abstract 
Cognitive decline is a prominent hallmark of brain aging, attributed in large part to age-
related changes at the neuronal synapse. Numerous synaptic properties are regulated 
by dynamic post-translational modifications (PTMs), like phosphorylation and O-
GlcNAcylation. However how this landscape changes with age, and its functional 
significance, has yet to be elucidated. Here, a proteomics study describing the aging 
synaptic phosphoproteome and O-GlcNAcome is reported. These analyses highlight the 
relevance of this resource to age-related cognitive decline and vulnerability to 
neurodegenerative disorders, including Parkinson’s and Alzheimer’s diseases. 
Ultimately, these findings propose dynamic PTMs as novel molecular drivers of brain 
aging, and provide the foundation for future mechanistic studies to investigate site-
specific molecular changes underlying synaptic and cognitive impairments during aging. 
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Introduction 
It is a well-appreciated notion that communication between neurons is a 
fundamental component of learning and memory regulation [1]. Learning elicits lasting 
alterations in synaptic plasticity that involve a wide array of cellular changes, many of 
which are localized to the synapse itself. A neuronal synapse is the meeting point of the 
pre-synaptic terminal (axonal bouton) of one neuron, and the post-synaptic terminal 
(dendritic spine) of another neuron, across which a signal is transduced in response to a 
stimulus such as a learning event (Figure 1).  
Signal transduction at synaptic connections is a complex and highly regulated 
process, initiated when an action potential reaches the axonal terminal and triggers 
sufficient influx of calcium into the cell. Pre-synaptic vesicles move from a reserve pool to 
a readily releasable pool, fuse with the pre-synaptic plasma membrane, and exocytose 
specialized molecules called neurotransmitters into the synaptic cleft. When glutamate, a 
major excitatory neurotransmitter of the central nervous system, crosses the synaptic 
cleft, it selectively binds to post-synaptic receptors such as N-methyl-D-aspartate 
receptor (NMDAR) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPAR). In addition to promoting the propagation of another action potential, activation 
of these post-synaptic receptors promotes numerous synaptic alterations, including 
trafficking of additional receptors to the cell surface, synaptic structural changes, and the 
activation of local signaling cascades (summarized in Figure 1). Neurons are each 
capable of forming thousands of synaptic connections with neighboring cells, establishing 
complex and highly organized neuronal networks, such as the tri-synaptic circuit in the 
hippocampus.          
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Figure 1. Schematic representation of a glutamatergic neuronal synapse. A 
Neuronal synapse is comprised of a pre-synaptic axonal terminal, a synaptic cleft, and a 
post-synaptic dendritic terminal. An action potential triggers calcium influx at the pre-
synapse, which promotes the mobilization of pre-synaptic vesicles, a process that 
involves pre-synaptic vesicle regulating proteins like Synapsin1. Vesicles fuse with the 
membrane and exocytose neurotransmitters like glutamate into the synaptic cleft. 
Glutamate binds to post-synaptic receptors like AMPAR and NMDAR, which are tethered 
to the surface by scaffolding proteins like PSD-95. Binding of glutamate elicits numerous 
changes, including receptor trafficking to the surface, influx of ions into the post-synapse, 
structural changes, and the activation of local signaling cascades.  
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With age, a diverse array of synaptic features and functions are impacted. Calcium 
homeostasis is disrupted in excitatory neurons of the aged hippocampal circuit [2]. 
Glutamate receptor subunit expression profiles shift during aging, and there is a proposed 
decrease in receptor function and trafficking during aging as well [3-5]. Synaptic structure 
and density are negatively impacted in the aging hippocampus [6-8] (Chapter 1, Figure 
3), and learning-induced synaptic remodeling is impaired in the prefrontal cortex as well 
[9]. At the molecular level, the composition of the synaptic protein fraction 
(synaptosome) has been characterized during aging using shotgun proteomics studies. 
These studies have characterized differential expression of pre-synaptic vesicle release 
proteins, signaling proteins mediating phosphatase activity, and cytoskeletal proteins 
involved in structural remodeling [10-12]. In addition, aging elicits reduced activity of 
kinases required for signaling cascades that promote plasticity [13, 14]. Collectively, this 
work demonstrates that extensive changes in synaptic features and functions have been 
characterized during aging. Despite these characterizations, however, the mechanisms 
that functionally regulate age-related synaptic and cognitive impairments have not been 
fully elucidated.  
 
Dynamic post-translational modifications and synaptic function 
Proteins at the pre- and post-synapse contain post-translational protein modifications 
(PTMs), in particular dynamic PTMs like phosphorylation and O-linked N-
acetylglucosaminylation (O-GlcNAcylation) [15]. Phosphorylation involves the reversible 
addition of a phosphate molecule onto serine, threonine, or tyrosine residues of 
proteins. Phosphate modifications are added to proteins by enzymes called kinases, 
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and removed by enzymes called phosphatases, of which there are hundreds [16] 
(Figure 2A). O-GlcNAcylation is a uniquely dynamic form of glycosylation involving the 
addition of a single sugar molecule, GlcNAc, onto serine and threonine residues of 
proteins. Unlike phosphorylation, however, O-GlcNAcylation is added to proteins by a 
single enzyme, O-GlcNAc transferase (Ogt) and is removed by a single enzyme called 
O-GlcNAcase (Oga) (Figure 2B). Intriguingly, protein phosphorylation and O-
GlcNAcylation regulate nearly every aspect of synaptic function, including features 
sensitive to aging like pre-synaptic vesicle dynamics, post-synaptic glutamate receptor 
trafficking, and structural remodeling [17-20].  
In support of this, a collection of literature attributes roles for these dynamic 
PTMs in regulating aspects of synaptic function and aging. Biochemical analysis of 
hippocampal tissue from learning-impaired aged rats has linked decreased 
phosphorylation of the AMPA receptor subunit GluR1 to cognitive impairments [5]. 
Conversely, pharmacological activation of the kinases PKA and PKC, which employ 
phosphorylation to mediate excitatory synaptic function, rescues synaptic impairments in 
aged Aplysia neurons [14]. O-GlcNAcylation has recently been demonstrated to regulate 
excitatory synapse maturation [21] and synaptic plasticity [22]. More broadly, decreased 
neuronal O-GlcNAcylation levels have been implicated in neurodegeneration [23, 24], 
and dementia-related diseases of aging [23]. Although there are emerging roles for 
dynamic PTMs in conditions of age-related synaptic decline, how the landscape of 
dynamic PTMs changes with age at the synapse has never been characterized.  
To address this gap in knowledge, a proteomics study employing isobaric labeling 
using tandem mass tagging followed by tandem mass spectrometry was performed. This 
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Figure 2.  Phosphorylation and O-GlcNAcylation are dynamic reversible forms of 
post-translational protein modification.  (A) Protein phosphorylation. Phosphate 
groups are added to the hydroxyl group on side chains of serine (Ser), threonine (Thr), or 
tyrosine (Tyr) amino acids by enzymes called kinases, and are removed by enzymes 
called phosphatases. (B) Protein O-GlcNAcylation. O-GlcNAc molecules are added to the 
hydroxyl group on side chains of serine (Ser), or threonine (Thr) amino acids by a single 
enzyme called Ogt, and removed by a single enzyme called Oga.   
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study provides the first relative quantitative assessment of site-specific synaptic PTMs in 
the young and aged mammalian synaptosome. 
 
Results 
 
Relative quantitation of dynamic PTM abundance on young and aged synaptic 
proteins using LC-MS/MS  
To strike a balance between obtaining sufficient staring material, and profiling brain 
regions most relevant to age-related impairments, hippocampal and cortical tissues 
were sub-dissected and pooled from a cohort of either young (3 month old) or aged (18-
20 month old) wild type mice (Figure 3A). Synaptosomes were isolated from fresh brain 
tissue using dounce homogenization, centrifugation, and separation on a sucrose 
gradient outlined in a previously published protocol [15] (Figure 3A). Western blot 
analysis was performed to confirm synaptosomes were free of gross contamination by 
nuclear markers Histone H3 and LaminB, and that they contained both pre- and post-
synaptic fractions by measuring Synapsin1 and PSD-95 (Figure 3B). Synaptic proteins 
were then prepared for mass spectrometry analysis, by reducing and alkylating cysteine 
side chains, followed by a trypsin digest to generate peptides (Figure 3C).  
 Peptides from each replicate were then separated into O-GlcNAc modified, 
phosphorylated, and unmodified samples. O-GlcNAcylated peptides were enriched for 
using lectin weak affinity chromatography (LWAC), and flow through was collected for 
subsequent enrichment of phosphorylated peptides using a TiO2–based approach 
(Figure 4A).  Peptides were then isobarically labeled by using a 6-plex tandem mass  
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Figure 3. Schematic for isolation of synaptic fractions from young and aged mice. 
(A) Schematic depicting enrichment paradigm of synaptic fractions (synaptosomes) 
from hippocampal and cortical brain tissue of young (3 month old) and aged (18–20 
month old) mice, n = 16–18 mice per age group. (B) Representative western blot 
analyses of synaptic (S.F.) and nuclear (P1) fractions, taken from a small aliquot of 
each sample. Lamin B and Histone H3 are nuclear markers, and PSD-95 and 
Synapsin1 are synaptic markers. (C) Proteins in synaptic fractions were prepared for 
mass spectrometry analyses by reduction and alkylation of cysteine side chain disulfide 
bonds, and trypsin digest to generate peptides.  
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tagging approach (TMT), such that distinct replicates from either age group were 
labeled with a tag containing a uniquely weighted balancer group (Figure 4B). Samples 
were then pooled together and profiled using a liquid chromatography tandem mass 
spectrometry (LC-MS/MS)-based approach. The relative abundance of dynamic PTMs 
were quantified using the peak intensities of the TMT fragment ions, and total protein 
abundance was also accounted for in order to specifically detect changes in PTM 
abundance above changes in protein expression. Higher energy collision dissociation 
(HCD) was employed for robust peptide identification and relative quantitation of TMT 
ions in all samples, as well as site-specific assignment of phosphorylation. O-GlcNAc is a 
particularly labile PTM and poses challenges for site-specific detection using HCD. Thus, 
to increase the resolution of O-GlcNAc site assignment electron-transfer dissociation 
(ETD) was also employed for O-GlcNAcylated peptides (Figure 4C).   
A total of 3,276 proteins were detected in the synaptosome, of which 0.67% 
increased and 1.37% decreased in abundance with age. Gene ontology (GO) terms for all 
proteins detected in the synaptosome were assessed using the ConsensusPathDB 
platform [25]. Compared against the entire mouse genome, the synaptosome contained 
overrepresented processes, functions, cellular components, and pathways consistent 
with synaptic structure and function (Figure 5A-D), indicating the fractions analyzed were 
significantly enriched for synaptic components.  
The overall distribution and abundance of phosphorylation and O-GlcNAcylation in 
the synaptosome was then assessed. A total of 7,621 unambiguous phosphorylation sites 
(phosphosites) were detected on  6,629 phosphorylated peptides (phosphopeptides) from  
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Figure 4. Tandem mass spectrometry-based characterization of age-related 
changes in synaptic phosphorylation and O-GlcNAcylation. Schematic depiction of 
liquid chromatography tandem mass spectrometry (LC-MS/MS) paradigm using to 
measure relative quantitative abundance of dynamic post-translational modifications 
(PTMs) in the aging synaptosome. (A) O-GlcNAcylated peptides were enriched for 
using lectin weak affinity chromatography (LWAC), and phosphorylated peptides 
enriched for using TiO2–based treatment. (B) 6-plex tandem mass tagging (TMT) was 
employed to allow for relative quantitation of PTM abundance. (C) Site-specific O-
GlcNAcylation was measured using electron-transfer dissociation (ETD). Site-specific 
phosphorylation, peptide identification, and relative quantitation of TMT ions was 
achieved using higher-energy collision dissociation (HCD).  
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Figure 5. Gene Ontology Analyses of the Synaptosome. (A) Gene ontology (GO) 
cellular component overrepresentation analysis of all proteins detected in the 
synaptosome dataset. Calculations were done using ConsensusPathDB with the mouse 
genome as the reference dataset, using false discovery rate (FDR) correction and a 
cutoff of P<0.01. (B) GO biological process overrepresentation analysis performed as 
described in (A). (C) GO molecular function overrepresentation analysis performed as 
described in (A). (D) GO pathway overrepresentation analysis performed as described 
in (A).  
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1,978 distinct proteins (phosphoproteins) (Figure 6A). A total of 197 unambiguous O-
GlcNAc sites were detected, on a total of 586 peptides from 175 proteins (Figure 6A). 
Additionally, 56.84% of all proteins were phosphorylated, 1.89% were O-GlcNAcylated, 
and 3.51% were both phosphorylated and O-GlcNAcylated (Figure 6B). These findings 
are within the normal range that has been reported for the relative abundance of 
phosphorylation versus O-GlcNAcylation [15]. 
Of proteins bearing unambiguous phosphorylation sites, 23.41% had increased 
phosphorylation, 28.97% had decreased phosphorylation, and 16.98% had two or more 
distinct sites that increased and decreased their phosphorylation with age (Figure 6B). Of 
proteins bearing O-GlcNAcylation sites, 12.00% had increased O-GlcNAcylation, 8.57% 
had decreased O-GlcNAcylation, and 1.14% had two or more distinct sites that increased 
and decreased their O-GlcNAcylation with age (Figure 6B). Together these initial 
analyses demonstrate that widespread and bi-directional alterations in phosphorylation 
and O-GlcNAcylation occur with age at the synapse.  
 
Characterization of the aging synaptic phosphoproteome. 
To begin the investigation of dynamic PTMs at the aging synapse, proteins with 
age-dependent changes in phosphorylation were characterized. Since protein 
phosphorylation can elicit activation, repression, or a host of other protein behaviors, both 
loss and gain of phosphorylation were considered important. Thus, all synaptic proteins 
upon which age-dependent changes in phosphorylation was detected were collectively 
termed: the aging synaptic phosphoproteome. More specifically, proteins with peptides 
containing up to two unambiguous phosphorylation sites that had an age–dependent 
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Figure 6. Summary of relative quantitative changes in the aging synaptic 
phosphoproteome and O-GlcNAcome. (A) Table depicting the total number of 
detected proteins, PTM-modified proteins, PTM-modified peptides, and unambiguous 
PTM sites in the synaptosome. (B) Pie charts representing changes in total protein 
abundance, the distribution of PTM modifications, and age-dependent changes in 
proteins and peptides with phosphorylation and O-GlcNAcylation.  
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change of at least 1.4-fold were included. A curated list of selected proteins, peptides, 
phosphorylation sites, and their direction and magnitude of change with age, is provided 
in Table 1.  
 Over 7,000 phosphorylation modifications were resolved to site-specificity using 
HCD, which also produced robust fragmentation of the peptide backbones, and cleavage 
of TMT ions. A representative spectrum of a peptide from the NMDA receptor subunit 2B 
(Grin2B/NR2B) is provided, wherein a phosphorylation site is detected at Serine residue 
1303 (Figure 7A). For this site, a relative 1.73-fold increase in phosphorylation with age 
was quantified using TMT reporter ions (Figure 7B). A representative schematic of the 
entire Grin2b protein is shown to depict the distribution of unambiguous phosphorylation 
sites that were detected over different regions of the protein, as well as their relative 
changes with age (Figure 7C). Many un-reported novel sites, as well as previously 
reported sites, were characterized across proteins in the phosphoproteome.   
 
Synaptic proteins with age-dependent changes in phosphorylation are involved in 
broad neuronal functions.  
To gain broad insight into how age-dependent changes in phosphorylation may influence 
synaptic functions or pathways, the aging synaptic phosphoproteome was analyzed using 
motif-x [26, 27], ConsensusPathDB [25], PANTHERdb [28], and STRING [29] platforms.  
Motif analysis of the phosphoproteome was performed using motif-x, on 
sequences that were 11 amino acids in length, with the central residue as an 
unambiguous phosphorylation site that changed with age. Peptides were separated 
based on phosphorylated residue and direction of change with age, and a significance  
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Table 1. Age-dependent changes in phosphorylation sites of synaptic proteins. 
This table contains a hand-curated list of proteins with age-dependent changes in 
phosphorylation. All modification sites are unambiguous. Phosphorylated residues are 
bolded and underlined in the peptide column. Fold change is depicted as aged/young, 
such that values > 1 indicate increased phosphorylation with age and < 1 indicate 
decreased phosphorylation with age. All N-termini of peptides and lysine residues are 
TMT-labeled and all cysteine residues are carbamidomethylated.  
Acc# Gene Protein Name Peptide Modification Site Change with Age
Fold Change  
Aged/Young
P11798 Camk2a MLTINPSKR Oxidation@251;Phospho@257=54 down 0.51800544
MLTINPSKR Phospho@253=57 down 0.31369255
MLTINPSKR Phospho@257=40 down 0.44686841
ITAAEALKHPWISHR Phospho@272=74 down 0.28974422
RITAAEALKHPWISHR Phospho@272=71 down 0.48424436
GAILTTMLATRNFSGGK Phospho@314=21 down 0.34518604
P23818 Gria1 Glutamate receptor 1 GFCLIPQQSINEAIR Phospho@849 down 0.59063027
P23819 Gria2 Glutamate receptor 2 NAQNINPSSSQNSQNFATYK Phospho@863=22 up 1.55874861
EGYNVYGIESVKI Phospho@880=54 down 0.64401157
P35438 Grin1 Glutamate receptor ionotropic, NMDA 1 AITSTLASSFK Phospho@890=7 down 0.55371949
P35436 Grin2A Glutamate receptor ionotropic, NMDA 2A SPDFNLTGSQSNMLK Phospho@890=18 down 0.65174058
KKSPDFNLTGSQSNMLK Phospho@890=11 down 0.68983121
GSLIVDMVSDK Phospho@929=79 down 0.69253675
SMESLRQDSLNQNPVSQR Oxidation@1018;Phospho@1025=39 up 2.19749081
QHSYDNILDKPR Phospho@1291=42 up 1.44543903
KMPSIESDV Phospho@1459=6 down 0.65620161
Q01097 Grin2B Glutamate receptor ionotropic, NMDA 2B NMANLSGVNGSPQSALDFIR Phospho@917=12 down 0.67037919
HSQLSDLYGK Phospho@1036=23 down 0.64554827
HSQLSDLYGKFSFK Phospho@1043=33 down 0.6671011
AGNLYDISEDNSLQELDQPAAPVAVSSNASTTK Phospho@1255=8 up 1.75716191
RQHSYDTFVDLQK Phospho@1303=22 up 1.45865488
RQHSYDTFVDLQKEEAALAPR Phospho@1303=24 up 1.79815836
QHSYDTFVDLQKEEAALAPR Phospho@1303=31 up 1.58350557
Q03391 Grin2D Glutamate receptor ionotropic, NMDA 2D RGSAHFSSLESEV Phospho@1313=34 up 2.19108803
P97772 Grm1 Metabotropic glutamate receptor 1 SNTFLNIFR Phospho@871=18 down 0.54738208
Q68EF4 Grm4 Metabotropic glutamate receptor 4 AVVTAATMSNKFTQK Phospho@870=23 down 0.58724556
Q3UVX5 Grm5 Metabotropic glutamate receptor 5 SSSLVNLWK Phospho@859=8 down 0.5674682
SSSLVNLWK Phospho@860=11 down 0.50760131
DSVDSGSTTPNSPVSESALC Phospho@1185=10 up 1.96640918
P42859 Htt Huntingtin DASGWFDVLQK Phospho@1368 down 0.51023776
SLNPQKSGEEEDSGSAAQLGMC Phospho@1853=28 up 1.75478542
SLNPQKSGEEEDSGSAAQLGMC Phospho@1853=11;Oxidation@1867 up 2.2520241
A2CG49 Kalrn Kalirin SFDLGSPKPGDETTPQGDSADEK Phospho@1789=24 up 1.84956211
DILGNKVSVK Phospho@2409 down 0.61531374
P63085 Mapk1 Mitogen-activated protein kinase 1 VADPDHDHTGFLTEYVATR Phospho@185=17 up 1.53278862
P46460 Nsf Vesicle-fusing ATPase QSIINPDWNFEK Phospho@207 down 0.62630135
TKENRQSIINPDWNFEK Phospho@207=7 up 1.51477997
KFLALMREEGASPLDFD Phospho@739 down 0.67279587
O88643 Pak1 Serine/threonine-protein kinase PAK 1 FYRSILPGDKTNK Phospho@57=20 down 0.68628447
KNPQAVLDVLEFYNSK Phospho@133=39 down 0.66970911
YMSFTDK Phospho@144=15 down 0.5258299
YMSFTDK Oxidation@143;Phospho@144=14 down 0.64860989
DVATSPISPTENNTTPPDALTR Phospho@223=6 up 1.56587232
Q8BLE7 Slc17a6 Vesicular glutamate transporter 2 SLGQIYR Phospho@23=63 down 0.62002144
P43006 Slc1a2 Excitatory amino acid transporter 2 DVEMGNSVIEENEMK Oxidation@509=95;Phospho@512 up 1.91297041
DVEMGNSVIEENEMK Oxidation@509;Phospho@512;Oxidation@519 up 2.13787458
NRDVEMGNSVIEENEMK Oxidation@509=56;Phospho@512 up 3.13368896
NRDVEMGNSVIEENEMK Oxidation@509;Phospho@512;Oxidation@519 up 3.71759882
KPYQLIAQDNEPEKPVADSETK Phospho@523=109 up 2.27749357
ESNSNQC Phospho@537=25 up 2.18183727
ESNSNQC Phospho@542=58 up 2.24186845
SADC Phospho@558=17 up 2.06337513
SADC Phospho@562=19 up 1.70604345
O88935 Syn1 Synapsin-1 ASTAAPVASPAAPSPGSSGGGGFFSSLSNAVK Phospho@67=7 down 0.66718764
QTTAAAAATFSEQVGGGSGGAGR Phospho@94=14 up 1.79073115
QTTAAAAATFSEQVGGGSGGAGR Phospho@103=39 up 1.71815263
SLKPDFVLIR Phospho@177 down 0.67476813
QPQRDASPGRGSHSQSSSPGALTLGR Phospho@427=13 up 1.84666045
DASPGRGSHSQSSSPGALTLGR Phospho@427=10 up 2.39609568
DASPGRGSHSQSSSPGALTLGR Phospho@432=7 up 2.00515188
QGPPLQQRPPPQGQQHLSGLGPPAGSPLPQR Phospho@494=55 up 1.80057628
LPSPTAAPQQSASQATPVTQGQGR Phospho@520=22 up 1.93996371
QSRPVAGGPGAPPAARPPASPSPQR Phospho@551=7 up 1.96874781
QSRPVAGGPGAPPAARPPASPSPQR Phospho@553=10 up 2.37028899
QASISGPAPTK Phospho@568=10 down 0.68733385
SQSLTNAFNLPEPAPPRPSLSQDEVK Phospho@666=8 up 1.57965952
Table 1: Age-dependent changes in phosphorylation sites of synaptic proteins
Calcium/calmodulin-dependent protein 
kinase type II subunit alpha
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Figure 7. Representative site-specific identification and relative quantitation of 
synaptic protein phosphorylation. (A) Representative HCD spectra identifies a 
phosphorylation site on the serine in the fourth position of the Grin2b peptide 
RQHSYDTFVDLQKEEAALAPR. The phosphorylated Ser1303 residue is shown in 
green. (B) TMT-6plex reporter ions used for relative quantitation. (C) Representative 
distribution of unambiguous phosphorylation sites and their change with age that were 
detected on the Grin2b protein. Some compositional features for Grin2b that are 
reported on UniProt have also been included.   
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cutoff of 0.000001 was employed (see methods for more details). Motif analysis 
identified 8 motifs with age-dependent increases in phosphorylation (Figure 8A), and 11 
motifs with age-dependent decreases in phosphorylation (Figure 8B). Potential kinases 
were assigned to these motifs based on a curated list compiled from the literature (Table 
2) [30]. Age-dependent increases in phosphorylation were detected on motifs consistent 
with casein kinase II (CK2) substrate motifs such as pSXX[E/D] and pS[D/E][D/E][D/E], 
where pS is a phosphorylated serine and X is any amino acid (Figure 8A; Table 2) [30]. 
Age-dependent decreases in phosphorylation were also detected on motifs consistent 
with CDK3, PKA, and PKC (Figure 8A; Table2) [30]. Alterations in motifs targeted by 
these kinases are suggestive of alterations in their function, with CK2 activity proposed 
to increase, and CDK3, PKA, and PKC activity proposed to decrease at the synapse 
with age. 
The aging synaptic phosphoproteome was next analyzed using 
ConsensusPathDB to profile overrepresentation of GO terms and pathways. Using the 
entire detected synaptosome proteome as a background dataset, GO analyses of the 
phosphoproteome identified biological processes indicative of neurogenic functions that 
are sensitive to aging, such as neurogenesis (Figure 9A). Overrepresented cellular 
components included both axonal and dendritic structures, demonstrating that age-
related changes in phosphorylation occur at both the pre- and post-synapse (Figure 9B). 
Molecular functions contained various kinase and other enzymatic activity terms, 
consistent with the notion that phosphorylation is a broad regulator of kinase and 
enzymatic activity (Figure 9C). From a total of 23 overrepresented pathways, neuronal 
system, PodNet network, and calcium signaling were most significant (Figure 9D). While  
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Figure 8. Position weight matrices of motifs with age-dependent changes in 
phosphorylation. Graphic sequence logos of position weight matrices (PMWs) 
depicting (A) motifs with phosphorylation sites that increased at the synapse with age 
and (B) motifs with phosphorylation sites that decreased at the synapse with age. The 
height of each amino acid letter corresponds to how tightly the residue is conserved 
within the enriched motif. PMWs were calculated using the motif-x platform.  
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Table 2. Motifs with age-dependent changes in phosphorylation and associated 
kinases. Kinases were matched with enriched motifs based on previously reported 
literature [30].  Motif score, fold increase, and all other parameters were calculated 
using the motif-x platform. See methods for more details.  
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Motifs with age-dependent increased phosphorylation 
Motif Motif Score Foreground Matches
Foreground 
Size
Background 
Matches
Background 
Size
Fold 
Increase Potential Kinases
.....S..E.. 16 396 2604 1011 10314 1.55 CK2
.....S....E 13.68 271 2208 711 9303 1.61 CK2
.....S.E... 12.44 263 1937 742 8592 1.57 CK2
.E...S..... 9.36 201 1674 604 7850 1.56 CK2
.....S...E. 8.26 141 1473 418 7246 1.66
..E..S..... 7.14 130 1332 411 6828 1.62 CK1; CK2
.....S.D... 6.47 148 1202 520 6417 1.52
....DS..... 6.58 111 1054 377 5897 1.65
Motifs with age-dependent decreased phosphorylation
Motif Motif Score Foreground Matches
Foreground 
Size
Background 
Matches
Background 
Size
Fold 
Increase Potential Kinases
.....SF.... 13.98 162 2266 384 10314 1.92 PKCs; Akt
.....SL.... 12.48 362 2104 1175 9930 1.45 Akt; p70 Ribosomal S6 kinase 
....LS..... 11 265 1742 879 8755 1.52 CDK4
.....S..F.. 11.1 90 1477 217 7876 2.21
...F.S..... 9.36 76 1387 191 7659 2.2
.....S.K... 8.94 113 1311 352 7468 1.83 PKC; PKA
...L.S..... 8.82 160 1198 586 7116 1.62 ERK1
.....SK.... 8.3 84 1038 267 6530 1.98
....FS..... 7.74 73 954 236 6263 2.03
.....S..L.. 6.81 111 881 458 6027 1.66
.....S....L 6.86 107 770 462 5569 1.68
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Figure 9. Synaptic proteins with age-dependent changes in phosphorylation are 
involved in a broad array of neuronal functions. (A-D) Gene ontology (GO) 
overrepresentation analyses of proteins with age-dependent alterations in 
phosphorylation. Calculations were done using ConsensusPathDB with the total set of 
proteins detected as the reference dataset, using false discovery rate (FDR) correction. 
Top five GO terms for each category, and top three pathways are shown. (E) Functional 
classification of proteins with age-dependent alterations in unambiguous 
phosphorylation was used to represent pathway distribution; performed using 
PANTHERdb. (F) Protein-protein interaction networks generated using STRING 
analysis of differentially phosphorylated proteins. A representative network is shown 
using proteins from the most overrepresented pathway as input. Line thickness denotes 
relative interaction strength. Nodes are color coded according to their association with 
GO terms in (A) and (D).  
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PodNet is a distinct network compiled using literature to describe protein-protein 
interactions in the podocyte cells of the kidney [31], many categorized genes are 
attributed dual roles in neuronal and synaptic function. In addition, functional classification 
of the aging synaptic phosphoproteome was assessed using PANTHERdb, and detected 
a wide distribution over 99 unique pathways, with enrichments in Gonadotropin-releasing 
hormone receptor pathway (GnRH), several G-protein signaling pathways, and 
metabotropic and ionotropic glutamate receptor pathways (Figure 9E).  
Induced protein-protein interaction network modeling was also performed using the 
STRING platform. The most significantly overrepresented pathway (neuronal system) 
was used as the input dataset for STRING modeling, due to the overall size of the 
phosphoproteome. The protein interaction network depicts proteins (nodes) and their 
physical interactions with one another (lines connecting nodes). A highly dense and 
interconnected network was generated, indicating that synaptic proteins with age-
dependent changes in phosphorylation undergo a large number of interactions with one 
another (Figure 9F). Proteins in the induced network were color coded according to their 
association with biological processes, such as neurogenesis (green) and calcium 
signaling (orange) (Figure 9A,D). A number of proteins in the network are associated with 
various processes, and are highly connected to other proteins, suggesting if changes in 
phosphorylation affect the functions of these proteins, neuronal processes like calcium 
signaling may be strongly impacted by age-dependent changes in phosphorylation. 
Furthermore, a few highly connected nodes, such as the NMDA receptor subunit Grin1, 
the calcium voltage gated channel subunit Cacna1a, and Dlg4, the gene which encodes 
PSD-95, were associated with multiple overrepresented processes and pathways from 
! 45!
GO analyses (Figure 9F). These nodes represent candidates that may elicit the greatest 
functional impact due to age-dependent changes in synaptic phosphorylation, as they are 
involved in numerous pathways. Together, these data implicate involvement of the aging 
synaptic phosphoproteome in broad neuronal functions, some of which are indeed 
sensitive to aging.  
 
Characterization of the aging synaptic O-GlcNAcome. 
To continue the investigation of dynamic PTMs at the aging synapse, proteins with age-
dependent changes in O-GlcNAcylation were characterized. Much like phosphorylation, 
O-GlcNAcylation elicits a wide array of protein behaviors. Thus, both loss and gain of O-
GlcNAcylation were also considered to be important. Similarly, all synaptic proteins upon 
which age-dependent changes in O-GlcNAcylation was detected were collectively 
termed: the aging synaptic O-GlcNAcome. More specifically, the aging synaptic O-
GlcNAcome refers to proteins exhibiting any age-dependent change in O-GlcNAcylation 
of at least 1.4-fold. A curated list of selected proteins, peptides, O-GlcNAcylation sites, 
and their direction and magnitude of change with age, is provided in Table 3.  
 O-GlcNAc is a particularly labile PTM, and poses challenges for site-specific 
detection using HCD. Thus, to increase the resolution of O-GlcNAc site assignment, 
electron-transfer dissociation (ETD) was employed on O-GlcNAcylated peptides. Using a 
combination of HCD and ETD, 586 O-GlcNAcylated peptides were detected, on which 
197 modifications were resolved to site-specificity (Figure 6A). A representative ETD 
spectrum used to resolve an unambiguous O-GlcNAcylation site on a peptide from the 
Ras/Rap GTP-ase activating protein (Syngap1) is provided, wherein an O-GlcNAc site is  
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detected at Threonine residue 1140 (Figure 10A,B). For this site, a relative 1.55–fold 
increase in O-GlcNAcylation was quantified with age using TMT reporter ions (Figure 
10B). A representative schematic of the entire Syngap1 protein depicts the distribution of 
all O-GlcNAc sites that were detected on the protein, as well as their relative change with 
age (Figure 10C). Much like in the phosphoproteome, many novel un-reported 
modification sites were characterized in the O-GlcNAcome.  
 
Synaptic proteins with age-dependent changes in O-GlcNAcylation are involved in 
glutamatergic signaling. 
The aging synaptic O-GlcNAcome was then analyzed using ConsensusPathDB 
[25], PANTHERdb [28], and STRING [29] platforms. GO analyses identified biological 
processes indicative of synaptic transmission, neurotransmitter secretion, and regulation 
of synaptic plasticity (Figure 11A). Cellular components were similar to those identified for 
the phosphoproteome, in that they contained both pre- and post-synaptic components 
(Figure 11B). In addition, ionotropic glutamate receptor complex was an overrepresented 
component (Figure 11B). Two molecular functions were detected, one of which was 
glutamate receptor binding (Figure 11C), and glutamatergic synapse was detected as the 
most overrepresented pathway (Figure 11D). Functional classification of the aging 
synaptic O-GlcNAcome using PANTHERdb identified a distribution over 9 unique 
pathways, of which ionotropic glutamate receptor pathway and synaptic vesicle trafficking 
were the two most populated (Figure 11E). Induced network modeling by STRING 
analysis revealed a single cluster, with two of the most highly connected nodes being 
Dlgap1, a protein of the NMDA-receptor-associated scaffolding complex [32], and the  
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Figure 10. Representative site-specific identification and relative quantitation of 
synaptic protein O-GlcNAcylation. (A) Representative ETD spectra identifying an O-
GlcNAc modification on the threonine residue in the eighth position of the Syngap1 
peptide QHSQTPSTLNPTMPASER. O-GlcNAcylated Thr1140 is shown in green. (B) 
TMT-6plex reporter ions used for relative quantitation, and O-GlcNAc fragment ions.  
(C) Representative distribution of O-GlcNAcylation sites and their change with age 
detected on the entire Syngap1 protein. Modifications with red borders have ambiguous 
site assignments. Compositional features for Syngap1 that are reported on UniProt 
have also been included.  
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Figure 11. Synaptic proteins with age-dependent changes in O-GlcNAcylation are 
involved in excitatory neuronal function.  
(A-D) Gene ontology (GO) overrepresentation analyses of proteins with age-dependent 
alterations in O-GlcNAcylation. Calculations were done using ConsensusPathDB with 
the total set of proteins detected as the reference dataset, using false discovery rate 
(FDR) correction. (E) Functional classification of proteins with age-dependent 
alterations in O-GlcNAcylation was used to represent pathway distribution; performed 
using PANTHERdb. (F) Protein-protein interaction networks generated using STRING 
analysis of differentially O-GlcNAcylated proteins. Line thickness denotes relative 
interaction strength. Nodes are color coded according to their association with GO 
terms in (A) and (D).  
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NMDA receptor subunit Grin2B (also known as NR2B). Other highly connected nodes 
were Shank1 and Shank2, of the Shank family of post-synaptic scaffolding proteins 
(Figure 11F). In contrast to broad functional involvement of the phosphoproteome (Figure 
9), the aging synaptic O-GlcNAcome suggests a more specific involvement in 
glutamatergic synaptic function, impairments of which in excitatory neurons are strongly 
linked to age-related cognitive decline [33].  
 
Discussion 
In this study, the first relative quantitation of age-dependent changes in 
phosphorylation and O-GlcNAcylation is characterized at the synaptic level. This 
proteomics approach combines high-standard PTM enrichment protocols, isobaric 
tandem mass tagging, and tandem mass spectrometry for optimized characterization. 
The present aging-associated synaptic phosphoproteome and O-GlcNAcome provide a 
rich dataset by which the scientific community can query synaptic proteins of interest for 
relative changes in site-specific PTM sites with age, and propose alterations in dynamic 
PTMs as a novel mechanism regulating synaptic and cognitive aging.  
Prior to this study, low throughput characterization of age-dependent alterations 
in PTMs required targeted MS experiments or the development of site-specific 
antibodies. High throughput microarrays for profiling PTMs, such as phosphorylation, 
have been developed but remain limited in their breadth of protein detection. While 
proteomics studies have previously profiled age-related changes in synaptic protein 
abundance [10, 11] or phosphorylation and O-GlcNAcylation at the young rodent 
synapse [15, 34, 35], these proteomics approaches have yet to be utilized in 
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combination, likely owing to a number of significant technical hurdles. For example, 
aged mammalian tissue is not easy to obtain in quantities large enough for the detection 
of low-stoichiometric PTMs on a sub-cellular level. O-GlcNAcylation in particular proves 
a challenging modification to enrich for given its low stoichiometric abundance 
compared to other PTMs. This study addresses these limitations by employing LWAC to 
enrich for O-GlcNAcylated peptides. Unlike chemical derivatization-based approaches 
LWAC does not require tagging, specialized capture, and cleavage for isolation. While 
indirect enrichment techniques such as BEMAD exist, they often require more nuanced 
conditions to prevent nonspecific labeling of other more abundant O-linked PTMs [36]. 
An additional concern is that O-GlcNAc modifications are quite difficult to detect on a 
site-specific level due to their extremely labile nature during peptide fragmentation. To 
circumvent this, HCD fragmentation was employed for robust peptide and 
phosphorylation site identification, in combination with ETD fragmentation for site 
assignment of O-GlcNAc.  
Phosphorylation mediates an enormous number of signaling pathways and 
cellular processes, and correspondingly, the proteomic analyses of the aging synaptic 
phosphoproteome identified GO terms and pathways involved in broad neuronal 
functions. Of note, pathways pertinent to brain aging, such as calcium signaling and 
glutamatergic receptor pathways were also detected. In particular, calcium signaling 
declines with age at glutamatergic synapses, suggesting that alterations in 
phosphorylation may contribute to age-related changes in excitatory neuronal signaling 
[37]. Functional classification identified changes in phosphorylation on proteins of the 
gonadotropin-releasing hormone (GnRH) receptor pathway, decline of which in the 
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hypothalamus promotes age-dependent cognitive impairments that are reversible by 
restoring GnRH signaling in the aged brain [38]. Motif analysis identified decreased 
phosphorylation at potential motifs corresponding to PKA and PKCs, which are strongly 
associated with excitatory synaptic transmission, and learning and memory, implicating 
dynamic PTMs in classic hallmarks of synaptic aging. Conversely, increased 
phosphorylation was identified on motifs corresponding to CK2. Increased activity of 
CK2 in neurons contributes to pathogenic hallmarks of Alzheimer’s and Parkinson’s 
disease [39, 40] – suggesting alterations in kinase activity at the aging neuronal 
synapse may contribute to the development of age-related neurodegenerative diseases.  
In contrast to the phosphoproteome, the aging synaptic O-GlcNAcome was 
comprised of far fewer sites that changed with age, likely owing to the naturally lower 
stoichiometric abundance of O-GlcNAc. Identified GO terms and pathways point to 
selective involvement of age-related changes in synaptic O-GlcNAcylation in 
glutamatergic neuronal function, known to decline in aging-sensitive brain regions 
including the hippocampus. Induced network modeling of the aging synaptic O-
GlcNAcome revealed that targets associated with the glutamatergic synapse pathway - 
Grin2b, Dlgap1, Shank1, Shank2 - are also highly connected nodes within the induced 
protein-protein interaction network. It is noteworthy that loss of the NMDA receptor 
subunit Grin2b in forebrain neurons elicits impairments in hippocampal-dependent 
cognition, while genetic neuronal overexpression of Grin2b prevents age-related 
cognitive decline [41, 42]. Of particular interest for future mechanistic investigations, 
these proteomic analyses identified a novel site of O-GlcNAc on Grin2b at either 
Ser1029 or Ser1030 that declined with age. While O-GlcNAc regulates the surface 
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localization and function of AMPA receptors [19, 43], its role in mediating NMDA 
receptor activity is unknown, with clear implications for age-related cognitive decline. 
Relevant to age-related neurodegenerative diseases, a decrease in O-GlcNAcylation 
was detected on alpha synuclein, likely at site Thr72. Interestingly, O-GlcNAcylation at 
this site has recently been shown to block alpha synuclein aggregation and toxicity, 
implicating a role for O-GlcNAc in Parkinson’s disease pathology [44]. More broadly, 
decreased protein O-GlcNAcylation has also been implicated in Alzheimer’s disease 
[23]. Together, these proteomics data raise the possibility that alterations in synaptic O-
GlcNAcylation may both drive brain aging and increase vulnerability to age-related 
neurodegenerative diseases.   
Collectively, this study characterizes for the first time the aging synaptic 
phosphoproteome and O-GlcNAcome, and proposes that investigating aging-associated 
changes in dynamic PTMs will prove critical to the understanding of brain aging. In 
particular, O-GlcNAcylation is proposed as a regulator glutamatergic synaptic function 
during aging, and therefore is heavily implicated as a regulator of cognitive decline. 
Moreover, these findings highlight dynamic PTMs as relevant to age-related 
neurodegenerative disorders, including Parkinson’s and Alzheimer’s disease. 
Ultimately, these data raise the possibility of targeting site-specific PTMs as potential 
interventions to ameliorate age-related cognitive decline and vulnerability to 
neurodegenerative disorders.  
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Materials and Methods  
 
Animal Models. All mouse handling and use was in accordance with institutional and 
ethical guidelines approved by the University of California San Francisco IACUC. The 
following mouse lines were used: C57BL/6 young and aged mice (National Institutes of 
Aging; Taconic Biosciences). All studies were done in male mice. The numbers of mice 
used to result in statistically significant differences were calculated using standard 
power calculations with α = 0.05 and a power of 0.8. We used an online tool 
(http://www.stat.uiowa.edu/~rlenth/Power/index.html) to calculate power and samples 
size based on experience with the respective tests, variability of the assays and inter-
individual differences within groups. Mice were housed under specific pathogen-free 
conditions under a 12 h light-dark cycle. All experiments were randomized and blinded 
by an independent researcher. Researchers remained blinded throughout histological, 
molecular, and behavioral assessments. Groups were un-blinded at the end of each 
experiment upon statistical analysis. 
 
Purification and Proteolytic digestion of Mouse Synaptosome. Cortical and 
hippocampal regions were isolated from fresh mouse brain tissue of either young (3 
month) or aged (18-20 month) mice (n=8-9 mice per biological replicate; n=2 biological 
replicates for young, n=1 biological and 2 technical replicates for old).  Synaptosome 
preparation was performed as previously described [15]. Frozen synaptosomal pellets 
were resuspended in 50mM ammonium bicarbonate containing 6M guanidine 
hydrochloride, 6X Phosphatase Inhibitor Cocktails II and III (Sigma-Aldrich), and 80mM 
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PUGNAc (Tocris Bioscience, Avonmouth, UK). Protein concentrations were estimated 
with bicinchoninic acid (BCA) protein assay (ThermoFisher Scientific, Rockford, IL). The 
mixture was reduced for 1 hour at 56ºC with 2mM Tris(2-carboxyethyl)phosphine 
hydrochloride  and subsequently carbamidomethylated using 4.2 mM iodoacetamide for 
45 min at room temperature in the dark. Lysates were diluted to 1M guanidine 
hydrochloride with 50 mM ammonium bicarbonate, pH 8.0, and equal amounts of each 
sample (7.3 mg) were digested overnight at 37°C with sequencing grade trypsin 
(ThermoFisher Scientific) at an enzyme to substrate ratio of 1:50 (w/w). Following 
digestion, samples were acidified with formic acid (FA) (Sigma-Aldrich), desalted using 
a 360-mg C18 Sep-Pak SPE cartridge (Waters), and dried to completeness using a 
SpeedVac concentrator (Thermo Electron). 
 
Lectin Weak Affinity Chromatography. Glycopeptides were enriched as described 
previously [15, 45]. Briefly, desalted synaptosome tryptic peptides were resuspended in 
500 µl LWAC buffer (100 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2, 10 mM CaCl2, 
5% acetonitrile) and 100 µl were run over a 2.0 x 250mm POROS-WGA column at 100 
µl/min under isocratic conditions with LWAC buffer and eluted with a 100 µl injection of 
40mM GlcNAc. Glycopeptides were collected inline on a C18 column (Phenomenex, 
Torrance, CA). Enriched glycopeptides from 5 initial rounds of LWAC were eluted with 
50% acetonitrile, 0.1% FA in a single 500 µl fraction, dried, and LWAC enrichment was 
repeated for a total of 3 enrichment steps. 
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Titanium Dioxide Phosphopeptide Enrichment. Peptides from LWAC flowthrough 
were acidified with FA and desalted with C18 reversed phase cartridges as above. 
Peptides were resuspended in 1.6 mL buffer B1 (200mM NaCl, 35% ACN, 0.4% TFA) 
and split into 4 aliquots. TiO2 enrichment of phosphopeptides was performed on an 
AKTA Purifier (GE Heathcare) using an in-house packed 2 mm x 2 cm guard column 
with 5 µm TiO2 beads (GL Sciences). Peptides were loaded at 2mL/min in buffer B1, 
washed with 0.1% TFA, and phosphopeptides were eluted onto an online C18 microtrap 
peptide column (Michrom Bioresources) with 1M KH2PO4 pH 3.0. C18-bound 
phosphopeptides were washed with 0.5% ACN, 0.1% TFA, and eluted with 50% ACN, 
0.1% TFA, pooled, and evaporated to dryness.  
 
TMT labeling and High pH Reverse Phase Chromatography. LWAC enriched 
glycopeptide eluates from young1, young2, and aged1 were split into two aliquots. One 
aliquot of young 1 and young 2 and both aliquots of aged 1 were labeled using the TMT-
6plex isobaric labeling system (ThermoFisher) according to the manufacturer’s protocol. 
TiO2-enriched phosphopeptide eluates from young1, young2, aged1, and aged2 and 
total proteins, represented by 200 µg of peptides from post-LWAC and TiO2 enrichment 
flowthrough, were also TMT labeled. The glycopeptide labeling was as follows: 
Young1:TMT128, Young2:TMT129, Aged1-1:TMT130, Aged1-2:TMT131. The 
phosphopeptide labeling was as follows: Young1:TMT128, Young2:TMT129, 
Aged1:TMT130, Aged2:TMT131. The ‘total protein’ peptides were labeled as follows: 
Young1:TMT127, Young2:TMT128, Aged1:TMT129, Aged2:TMT130. Labeling 
efficiency and mixing ratios were checked on small aliquots of the labeling reaction on 
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an AB Sciex/ABI QSTAR Elite Q-TOF. TMT labeled peptides were mixed together at a 
1:1:1:1 molar ratio and fractionated by high pH RP liquid chromatography. 
Glycopeptides were separated on a 1.0 × 100 mm Gemini 3µ C18 column 
(Phenomenex, Torrance, CA). Peptides were loaded onto the column in 20 mM 
NH4OCH3, pH 10 and subjected to a gradient from 1% to 21% 20mM NH4OCH3, pH10 
in 50% acetonitrile over 1.1 ml, up to 62% 20mM NH4OCH3, pH10 in 50% acetonitrile 
over 5.4 ml with a flow rate of 80 µl/min while collecting 24 fractions. TMT-labeled 
phosphopeptides were separated by high pH reverse phase chromatography on the 
AKTA purifier with a 1 x 100mm Gemini 3um C18 column (Phenomenex). Peptides 
were loaded onto the column in 20mM NH4OCH3, pH 10 and eluted off the column over 
a gradient from 2% to 70% 20mM NH4OCH3, pH 10 in 90% ACN.TMT labeled-peptides 
from total proteins were fractionated on a 4.6 × 150 mm Gemini 5µ C18 column 
(Phenomenex) with a gradient from 1% to 9% 20mM NH4OCH3, pH10 in 90% 
acetonitrile over 2 min, then to 49% over 20 min and finally to 70% over 1.5 min. Forty-
five fractions were collected and dried. Every other fraction was resuspended in 0.1% 
FA for mass spectrometry analysis. 
 
Mass Spectrometry Analysis. All samples were analyzed on an Orbitrap Velos 
(Thermo Scientific, San Jose, CA) equipped with a nano-Acquity UPLC (Waters, 
Milford, MA). Peptides were fractionated on a 15cm x 75 µm ID 3µm C18 EASY-Spray 
column using a linear gradient from 2-35% solvent B over 60 min. Survey mass 
measurements were performed in the Orbitrap, scanning from m/z 350-2000. The 3 
most abundant multiply charged ions were computer-selected for analysis by both HCD 
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and ETD with supplemental activation. The trigger intensity was set to 2000. 
Supplemental activation was enabled. The ETD fragments were measured in the linear 
trap, whereas HCD fragments were measured in the Orbitrap. Each LWAC enriched 
sample was injected twice; the first analysis selected only 2+ precursor ions and in the 
second analysis 2+ precursor ions were excluded. Peaklists were extracted using 
Proteome Discoverer 1.4. ETD data was searched against the UniProt Mus musculus 
database (downloaded December 1, 2015) (and concatenated with a randomized 
sequence for each entry) using Protein (v5.10.15). Cleavage specificity was set as 
tryptic, allowing for 2 missed cleavages. Carbamidomethylation of Cys and TMT6plex 
on lysine and the N-terminus were set as constant modifications. The required mass 
accuracy was 10 ppm for precursor ions and 0.8 Da for ETD fragments. Variable 
modifications included acetylation of protein N-termini, oxidation of Met, cyclization of N-
terminal Gln, and HexNAc modification of Ser, Thr, and Asn as variable modifications. 
The following extended O-linked glycans on Ser or Thr: HexNAc2, HexNAcFuc, 
HexNAcHexFuc, HexNAcHexSA, HexNAcHexSA2, HexNAcHexSAAc, 
HexNAcHexSAAc2, HexNAcSA and the following extended N-linked glycans on Asn; 
HexNAc2, HexNAc2Fuc, HexNAc2Hex, HexNAc2Hex10, HexNAc2Hex2, 
HexNAc2Hex2Fuc, HexNAc2Hex3, HexNAc2Hex3Fuc, HexNAc2Hex4, 
HexNAc2Hex4Fuc, HexNAc2Hex5, HexNAc2Hex5Fuc, HexNAc2Hex6, HexNAc2Hex7, 
HexNAc2Hex8, HexNAc2Hex9, HexNAc2HexFuc, HexNAc3Hex3, HexNAc3Hex3Fuc, 
HexNAc3Hex4, HexNAc3Hex5, HexNAc3Hex6, HexNAc3Hex7, HexNAc4Hex3, 
HexNAc4Hex3Fuc, HexNAc4Hex4, HexNAc4Hex5, HexNAc4Hex5SA2, 
HexNAc4Hex6Fuc, HexNAc4Hex6SA, HexNAc5Hex3, HexNAc5Hex3Fuc, 
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HexNAc5Hex4, HexNAc5Hex4Fuc, HexNAc5Hex4NeuAc, HexNAcFuc, were set as 
rare variable modifications. Those modifications on Asn were permitted only within the 
N-linked consensus motif NX(S/T) were X cannot be Pro [46]. Three modifications per 
peptide were permitted. Unambiguous PTMs were determined using a minimum SLIP 
score of six, which corresponds to a 5% local FLR. HCD data were searched with the 
same parameters except that fragment ion mass accuracy was 30 ppm and the only 
glycans set as variable modifications were HexNAc on Asn (set as rare within the 
NX(S/T) motif), Ser, Thr, and as a neutral loss. Modified peptides were identified with a 
protein and peptide false discovery rate of 1%. O-GlcNAc and O-GalNAc modifications 
were differentiated based on known protein subcellular localization and HexNAc 
oxonium ion fragment ratios [47]. TiO2-enriched peptides and non-enriched peptides 
were run and analyzed as above with the following differences. The 6 most abundant 
multiply charged ions were selected for HCD fragmentation and measurement in the 
Orbitrap. The variable modifications were the same as for the glycopeptide searches 
except that no glycosylation was considered and Phospho on S, T, and Y was chosen 
for the TiO2-enriched samples.  
 
TMT Mass Spectrometry Data Analysis. Data was filtered to only include peptides 
unique to a single protein. Quantitation of TMT data was performed by calculating ratios 
of reporter ion peak intensities between conditions along with variance for each ratio, 
and median normalized. Reporter ion peak intensities were obtained from HCD spectra. 
For glycopeptide analysis, when a peptide was identified by ETD only, the reporter ion 
peak intensities were used from the preceding HCD scan of the same precursor ion. 
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Peptide abundances were normalized by the median of ratio distributions. The 
significant age-dependent changes in the phosphorylation and O-GlcNAcylation 
datasets were determined using a normalized median Log2 aged/young ratio of at least 
0.5, corresponding to a 1.4 fold change with age. This cutoff corresponded to 3 times 
the average standard deviation of the median Log2 aged/young ratio of all peptides with 
more than one data point.  
 
Gene Ontology, Pathway, Induced Network, and Motif-x Analyses. The online 
PANTHER [28] platform was used to calculate gene ontology (GO) overrepresentation 
analyses and functional classification of pathways for the phosphorylation and O-
GlcNAcylation datasets. The entire detected MS/MS dataset was used as a reference 
dataset for statistical overrepresentation analyses. Cutoff was P<0.05, and Bonferroni 
correction for multiple testing was used. Pathway overrepresentation analyses were 
calculated using ConsensusPathDB [25]. The entire detected MS/MS dataset used as a 
reference in both phosphorylation and O-GlcNAcylation dataset analyses. Cutoff was 
P<0.05, and p-values were corrected for multiple testing using the false discovery rate 
method. Sources used for pathway overrepresentation were Reactome, Wikipathways, 
Kegg, and Mousecyc databases. Induced network models were represented using the 
STRING [29] platform, and generated using curated databases, experimentally 
determined co-expression, text mining, gene neighborhood, gene co-occurrence, gene 
fusions, and protein homology. The O-GlcNAcylation network was calculated using all 
proteins with significant changes in O-GlcNAcylation. The representative induced 
network model for the phosphorylation dataset was produced using targets from the 
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highest overrepresented pathway and the highest confidence interaction score, given 
the size of the dataset. An increase in line thickness between nodes denotes an 
increase in relative interaction confidence, as represented by the STRING platform. 
Phosphorylation motifs were calculated using motif-x [26, 27]. Analysis was performed 
on sequences 11 amino acids in length centered on unambiguous sites of 
phosphorylation (S, T, or Y). Peptides were separated into mini datasets for analysis by 
phosphorylated amino acid type, and by direction of change with age. The background 
dataset for each run included all single unambiguous phosphorylation sites in the 
synaptosome for S, T, or Y, extended from the mouse IPI database, with occurrences 
set to 20 and significance cutoff set to 0.000001.  
 
Data and statistical analysis. Graphed data are expressed as mean ± SEM. Statistical 
analysis was performed with Prism 5.0 software (GraphPad Software). Means between 
two groups were compared with two-tailed, unpaired Student’s t-test. Comparisons of 
means from multiple groups with each other or against one control group were analyzed 
with 2-way ANOVA and Bonferroni post hoc tests. All histology, electrophysiology and 
behavior experiments conducted were done in a randomized and blinded fashion. For 
each experiment, the overall size of the experimental groups corresponded to distinct 
animals. Unique samples were not measured repeatedly within the same 
characterization of a given cohort.  
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Abstract 
Aging elicits impairments in learning and memory, largely attributed to age-related 
changes in excitatory neurons of brain regions such as the hippocampus. Recent work 
has identified a dynamic form of intracellular protein glycosylation called O-linked N-
Acetylglucosamine (O-GlcNAc) as a regulator of excitatory neuronal function. It has 
remained unclear, however, how O-GlcNAc may regulate aspects of neuronal and 
cognitive aging. A decrease in O-GlcNAc and O-GlcNAc Transferase (Ogt), the enzyme 
that adds O-GlcNAc to proteins, was detected in the hippocampus of aging mice. To 
investigate a role for O-GlcNAc in regulating phenotypes of hippocampal aging, a 
temporally controlled conditional knockout mouse was generated to ablate Ogt in adult 
excitatory forebrain neurons. The findings indicate that loss of Ogt and reduced O-
GlcNAcylation elicit alterations in neuronal molecular, synaptic, and cognitive function, 
many of which are reminiscent of phenotypes observed during aging. Furthermore, this 
study proposes that reduced hippocampal O-GlcNAc during aging is a driver of 
hallmarks like synaptic loss and impaired learning and memory.   
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Introduction 
Recent work has highlighted O-linked N-Acetylglucosamine (O-GlcNAc), a uniquely 
dynamic form of intracellular post-translational glycosylation, as an attractive target for 
regulating neuronal function during aging. The addition of O-GlcNAc to serine or 
threonine residue of proteins is catalyzed by an enzyme called O-GlcNAc Transferase 
(Ogt), and is removed from proteins by an enzyme called O-GlcNAcase (Oga). O-GlcNAc 
has been linked to lifespan in C. elegans, with loss of Ogt shortening lifespan and 
promoting early aging phenotypes [1, 2]. In excitatory neurons, Ogt knockout during early 
post-natal development elicits neuronal cell death, neurodegenerative phenotypes, and 
impaired contextual memory in mice [3, 4]. At the synaptic level, O-GlcNAc has been 
attributed a role for mediating the structure and formation of excitatory neuronal synapses 
in vitro [5]. Additionally, loss of Ogt in hypothalamic neurons elicits a decrease in post-
synaptic current, suggesting O-GlcNAc plays a role in mediating synaptic function [6]. In 
support of this, pharmacological approaches have linked O-GlcNAc to long-term 
potentiation (LTP) and long term depression (LTD), to two counteracting synaptic 
processes both critical for proper memory formation [7, 8].  
 Collectively, the literature supports a role for O-GlcNAc in mediating features of 
excitatory neuronal and synaptic function. Studies involving the hippocampus 
demonstrate robust neurodegenerative phenotypes upon loss of Ogt, but have utilized a 
non-temporally inducible knockout model that may not exclude contributions from early 
post-natal development [3, 4]. To date, roles for O-GlcNAc in regulating excitatory 
neuronal and cognitive function in the developmentally mature hippocampus, and in the 
context of aging, have not been investigated.  
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Thus, in this study, Ogt and O-GlcNAc are investigated in the adult and aging 
hippocampus, given this brain region demonstrates stereotypic alterations in neuronal 
and synaptic function that coincide with age-related cognitive decline (see Chapter 1). 
This study demonstrates necessary roles for Ogt and O-GlcNAc in maintaining mature 
adult excitatory neuronal, synaptic, and cognitive functions. Furthermore, loss of 
excitatory neuronal Ogt and reduction of O-GlcNAc recapitulate many aging-related 
phenotypes in vivo. These findings propose that alterations in neuronal O-GlcNAcylation 
promote synaptic and cognitive impairments in the aging brain.  
 
Results 
 
Aging elicits a decrease in hippocampal protein O-GlcNAcylation  
To begin this investigation, protein O-GlcNAcylation and Ogt expression were profiled in 
the hippocampus during aging. Hippocampal tissue was isolated from young (3 month 
old) or aged (18-24 month old) wild type mice and profiled using western blot analysis. A 
decrease in global protein O-GlcNAcylation, as well as a decrease in Ogt protein levels 
were both observed in aged hippocampi (Figure 1A,B). Collectively, the literature 
supports a role for O-GlcNAc in regulating excitatory neuronal function, and the data 
herein demonstrate aging elicits decreased O-GlcNAcylation and Ogt, in addition to 
hippocampal impairments (Chapter 1). Therefore, the question was raised as to whether 
reducing O-GlcNAcylation, specifically in excitatory neurons of the adult hippocampus, 
could elicit features of brain aging in a young mouse.  
 
! 75!
 
    
      
 
 
Figure 1. Aging elicits a decrease in O-GlcNAcylation and Ogt protein levels in the 
hippocampus. (A) Representative bands showing global protein O-GlcNAcylation, 
assessed in whole hippocampal lysates from young (3 month old) and aged (24 month 
old) mice. Quantification of global protein O-GlcNAcylation mean intensity, normalized 
to GAPDH as a loading control and shown as fold change from young. n = 3-4 mice per 
group. (B)  Representative bands of Ogt protein, assessed in whole hippocampal 
lysates from young (3 month old) and aged (18 month old) mice. Quantification of Ogt 
mean intensity, normalized to GAPDH as a loading control and shown as fold change 
from young. n = 4 mice per group. Data represented as mean ± SEM *P<0.05; 
**P<0.01; t-test.   
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Decreased excitatory neuronal O-GlcNAcylation elicits aging-associated neuronal 
phenotypes in vivo 
In order to investigate the effects of decreased neuronal O-GlcNAcylation, an Ogtflox/y 
mouse model was generated, carrying an inducible CamK2a-Cre-ERT2 gene in which 
Ogt is excised specifically in young adult excitatory forebrain neurons upon tamoxifen 
administration (Ogt-cKO mouse) (Figure 2A). Decreased Ogt and global protein O-
GlcNAcylation were confirmed in hippocampal lysates of Ogt-cKO mice when compared 
to Ogtflox/y littermate controls (Figure 2B,C). As expected, no significant changes in Ogt 
and O-GlcNAc expression were detected outside of the forebrain region in the 
cerebellum (Figure 2D,E).  
Previous work using a non-inducible mouse model, in which Ogt is excised in 
CamK2a-expressing neurons during early postnatal development, reports neuronal loss 
and increased apoptosis in the hippocampi of knockout mice during late adulthood [3, 
4]. Here, hippocampal cell loss was assessed in Ogt-cKO mice using Cresyl violet 
staining for Nissl bodies and immunohistological staining for the apoptosis marker 
cleaved caspase 3. By contrast, no changes in widespread cell loss or apoptosis were 
detected in either CA1 or DG neuronal sub-regions upon acute conditional loss of Ogt 
(Figure 3A-D), in line with what is also observed in aging wild type mice (Figure 1C,D).  
Next, molecular and structural changes were profiled in hippocampal neurons of 
Ogt-cKO and control mice by immunohistochemistry and Golgi analysis, employing the 
same characterizations performed on young and aged mice in Chapter 1. 
Phosphorylation was profiled at site Ser133 on the transcription factor Creb (pCreb), 
which promotes synaptic plasticity and immediate early gene (IEG) expression, and  
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Figure 2. Generation of the Ogt-cKO mouse model. (A) Schematic depicting the 
timeline for the generation of and subsequent experiments using the young adult (4 
month old) conditional excitatory neuron Ogt knockout mouse (Ogt-cKO). (B) Western 
blot of O-GlcNAc modifications and Ogt protein levels from whole hippocampal lysates 
of control and Ogt-cKO mice. (C) Quantification of (B) normalized to GAPDH and 
represented as fold change normalized to control. (D) Western blot of O-GlcNAc 
modifications and Ogt protein levels from whole cerebellar lysates of control and Ogt-
cKO mice. (E) Quantification of (D) normalized to GAPDH and represented as fold 
change normalized to control. n=3 mice per group. Data represented as mean ± SEM 
*P<0.05; t-test. 
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Figure 3. Ogt-cKO mice do not display increased cell loss or apoptosis in the 
hippocampus. (A) Representative field of Nissl stain in the hippocampus of young Ogt-
cKO and control mice. (B) Quantification of Nissl stain mean intensity in CA1 region of 
the hippocampus. (C) Representative immunohistochemical DAB stain of cleaved 
caspase 3 (CC3) in hippocampal regions of young control and Ogt-cKO mice. (D) 
Quantification of average total CC3+ cells in CA1 and DG neuronal sub-regions; n = 4 
mice per group. Data represented as mean ± SEM; t-test. (E) A positive control known 
to have CC3+ brain cells was included to ensure the staining was accurate. Scale bars 
= 200 µm. 
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decreases with age in the hippocampus (Chapter 1; Figure 2C,D) [9, 10]. Similarly to 
what is observed during aging, a reduction in pCreb mean intensity was detected in 
neurons of both the CA1 and DG sub-regions in Ogt-cKO compared to control mice 
(Figure 4A,B). Additionally, cFos was profiled in the hippocampi of Ogt-cKO and control 
mice. cFos is an IEG downstream of Creb, a marker of neuronal activity, and also 
declines with age in hippocampal neurons (Chapter 1; Figure 2E,F) [11, 12]. A reduction 
in the number of cFos-positive activated neurons was also detected in the CA1 region of 
Ogt-cKO mice (Figure 4C,D). Given that pCreb and cFos regulate synaptic plasticity, 
the question was raised as to whether Ogt-cKO mice displayed alterations in neuronal 
structure at the synaptic level.  
A second cohort of young Ogt-cKO and control mice was then characterized with 
a Golgi stain, to label the cell body and synaptic structures of mature neurons. Ogt-cKO 
mice displayed a reduction in the number of tertiary dendritic spines on CA1 pyramidal 
neurons when compared to controls (Figure 5A,B), reminiscent of CA1 neurons in the 
hippocampi of aging mice (Chapter 1, Figure 3A,B). Taken together these in vivo data 
indicate that decreased O-GlcNAcylation in adult excitatory neurons recapitulates 
certain hallmarks of neuronal molecular and synaptic aging in the adult hippocampus.  
 
Decreased excitatory neuronal O-GlcNAcylation alters hippocampal synaptic 
protein expression and function 
Given that histological and Golgi analyses were indicative of alterations in 
synaptic structure and plasticity, synaptic proteins were next assessed using western  
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Figure 4. Decreased O-GlcNAcylation in excitatory neurons elicits aging-
associated molecular changes. (A) Representative field of pCreb immunostain in the 
hippocampus of young Ogt-cKO and control mice. Scale bar = 200 µm. (B) 
Quantification of pCreb mean intensity in the DG or CA1 region, n = 3 mice per group. 
(C) Representative field of cFos immunostaining in the hippocampus of young Ogt-cKO 
and control mice. Scale bar = 200 µm. (D) Quantification of cFos-positive cells in the 
CA1 region of the hippocampus of young Ogt-cKO and control mice, n = 4 mice per 
group. Data represented as mean ± SEM *P<0.05; **P<0.01; t-test (B,D).  
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Figure 5. Decreased O-GlcNAcylation elicits reduced dendritic spine density in 
CA1 pyramidal neurons of Ogt-cKO mice. (A) Representative field of Golgi stain from 
DG granule cell neurons and CA1 pyramidal neurons in young Ogt-cKO and control 
mice. (B) Quantification of spine number from tertiary dendrites of DG granule cell 
neurons and CA1 pyramidal neurons in Ogt-cKO and control mice, n = 5 mice per 
group, n = 10 neurons per mouse. Data represented as mean ± SEM *P<0.05; 
**P<0.01; t-test. 
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blot analyses. Several synaptic markers that have been reported to change with age 
were characterized in hippocampal lysates from Ogt-cKO versus control mice. The post-
synaptic scaffolding protein PSD-95, pre-synaptic vesicle endocytosis protein 
Synaptophysin, and vesicle release regulating protein Synapsin1 all have been reported 
to decline in the hippocampus with age [13, 14]. Indeed, Ogt-cKO mice displayed 
reduced hippocampal levels of these three proteins when compared to controls (Figure 
6A,B). In addition, subunits 2A and 2B of the post-synaptic Glutamate receptor N-
methyl-D-aspartate receptor (NMDAR) were profiled by western blot as well. A change 
in the ratio of NR2A/NR2B often used as an indicator for potential alterations in synaptic 
function [15]. A decrease the protein levels of both NR2A and NR2B, and a modest 
decrease in the NR2A/NR2B ratio was observed in the hippocampi of Ogt-cKO versus 
control mice (Figure 6A,B). Hippocampal NR2B protein does selectively decline with 
age, although the ratio of NR2A/NR2B typically increases with age alongside increased 
LTD and decreased LTP [16, 17]. Overall, Ogt-cKO mice display some changes in 
synaptic protein expression that are reminiscent of aging, as well as changes that 
collectively are suggestive of altered synaptic function.  
To expand upon these findings, extracellular electrophysiological recordings 
were performed to measure synaptic function in hippocampal slices in a third cohort of 
Ogt-cKO and control mice. Electrophysiological recordings were performed specifically 
on Schaffer collateral projections from the CA3 to CA1 region (Figure 7A), given the 
CA1 demonstrated increased sensitivity to the effects of the Ogt knockout. The input-
output relationship was calculated by plotting the amplitude of presynaptic volleys with 
the resulting slope of the evoked field excitatory post synaptic potential (fEPSP). No 
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Figure 6. Decreased O-GlcNAcylation in excitatory neurons alters hippocampal 
synaptic protein expression. (A) Representative Western blot of synaptic proteins 
PSD-95, Synaptophysin, Synapsin-1, NR2A, and NR2B from whole hippocampal 
lysates of young Ogt-cKO and control mice. (B) Quantification of synaptic proteins, 
represented as fold change from control group. GAPDH and β-Tubulin used as loading 
controls, with PSD-95, Synapsin-1, NR2A, and NR2B normalized to GAPDH and 
Synaptophysin normalized to β-Tubulin. n = 3 mice per group. Data represented as 
mean ± SEM *P<0.05; **P<0.01; ****P<0.0001; t-test (B). 
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difference was detected, indicating there was no overall change in synaptic strength 
between Ogt-cKO and control mice (Figure 7B). Next, paired-pulse ratio (PPR) was 
measured to assess presynaptic release probability. Similarly, no significant difference 
was detected between control and Ogt-cKO mice (Figure 7C). These results suggest 
Ogt-cKO mice exhibit normal basal synaptic transmission from CA3 to CA1 compared to 
controls. In order to investigate long-term changes in synaptic function in response to a 
stimulus, LTP and LTD were measured as well. No difference was observed in LTD 
(Figure 7D,E), however, a modest but significant increase in LTP was detected in Ogt-
cKO compared to control mice (Figure 7F,G). There was also a moderate inverse 
correlation between LTP and hippocampal Ogt protein expression (Figure 7H). 
Additionally, the increased LTP observed in Ogt-cKO mice logically follows the 
decrease observed in the NR2A/NR2B ratio (Figure 6A,B) [18]. These data indicate that 
decreased neuronal O-GlcNAcylation alters hippocampal LTP, an excitatory synaptic 
process that is strongly associated with memory regulation [19, 20].   
 
Ogt-cKO mice display impaired hippocampal-dependent learning and memory 
Given that alterations in synaptic structure, composition, and function were observed in 
Ogt-cKO mice, cognitive testing was performed to investigate the consequences of 
these alterations. In particular, forms of learning and memory sensitive to the effects of 
hippocampal aging were assessed in a separate large cohort of Ogt-cKO and control 
mice. Anxiety and general motor function were profiled using open field, as well as 
hippocampal-dependent learning and memory using RAWM and fear conditioning 
paradigms (Figure 8A).  
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Figure 7. Decreased O-GlcNAcylation in hippocampal excitatory neurons alters 
long-term potentiation at CA3-CA1 Schaffer collateral projections. 
(A) Schematic for electrophysiological recordings in CA3-CA1 neuronal projections, 
performed in ex vivo hippocampal slices from young adult Ogt-cKO or control mice. (B) 
Basal transmission of CA3-CA1 measured as the Input-output relationship between 
presynaptic fiber volley amplitude and the slope of the resulting fEPSP. in acute 
hippocampal slices from 8-10-week-old control and Ogt-cKO mice, n = 10 slices / 7 
animals, n = 7 slices / 3 animals, respectively.(C) Paired-pulse facilitation measured at 
various timing delays. (D) LTD recordings in the CA1 region of the hippocampus. fEPSP 
slope is plotted as percentage of baseline average. Recordings were performed in acute 
hippocampal slices from 8-10-week-old control and Ogt-cKO mice, n = 10 slices / 7 
animals, n = 7 slices / 3 animals, respectively) induced via 15 min single-pulse low-
frequency stimulation (SP-LFS) (1hz). (E) Bar graphs summarizing the average fEPSP 
slopes as a percentage of baseline, measured in the last 5 min of recording. (F) LTP 
recordings in the CA1 region of the hippocampus of Ogt-cKO and control mice. fEPSP 
slope is plotted as percentage of baseline average. Electrophysiological recordings 
were performed in acute slices from 8-10-week-old control and OGT-cKO mice n = 10 
slices / 6 animals, n = 13 slices / 7 animals, respectively, LTP was induced via 4 trains 
of 100hz stimulation. (G) Bar graphs summarizing the average fEPSP slopes as a 
percentage of baseline, measured in the last 5 min of recording. (H) LTP magnitude 
shows a moderate correlation with levels of Ogt protein. Ogt levels measured via 
western blot and plotted against average magnitude of LTP during last 5 min of 
recording. Data represented as mean ± SEM; *P<0.05; t-test (E,G). 
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Figure 8. Ogt-cKO mice display impairments in hippocampal learning and 
memory. (A) Schematic depicting generation of Ogt-cKO mice and subsequent 
cognitive testing using open field, radial arm water maze (RAWM), and fear conditioning 
behavioral paradigms. (B) Data from the open field paradigm depicting percent time 
spend in periphery and center of the field, as well as basic movements, fine 
movements, and rearing behavior of Ogt-cKO and control mice. Data shown are 
cumulative from ten minutes of testing, measured using the MotorMonitor software. (C-
E) Hippocampal-dependent spatial learning and memory was assessed in Ogt-cKO and 
control mice using RAWM. Quantification of the number of entry errors during RAWM 
training and testing (C), short-term memory testing (D) and long-term learning and 
memory testing (E), n =10-15 mice per group. (F) Baseline, contextual, and cued fear 
memory was assessed in Ogt-cKO and control mice using fear conditioning. Baseline 
freezing was measured during the first two minutes of training. Freezing in contextual 
and cued conditions was measured 24 hours after training, n = 10-15 mice per group. 
Data represented as mean ± SEM; *P<0.05; **P<0.01; ***P<0.001; repeated measures 
ANOVA, column factor (C); t-test (B,D,E,F).  
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Ogt-cKO mice did not spend significantly more time in the periphery or center of 
the open field during testing, indicative of no differences in general anxiety between 
groups (Figure 8B). However, Ogt-cKO mice did display decreased basic and fine 
movements during the open field test, as well as decreased rearing (Figure 8B).  
When testing spatial learning and memory using RAWM, all mice showed similar 
learning capacity during the training phase (Figure 8C), and no difference in short-term 
memory during the testing phase on day 1 (Figure 8D). However, Ogt-cKO mice 
committed more errors as a whole in locating the target platform during long-term 
memory testing compared to control animals, similarly to what is observed in aging mice 
(Figure 8C; Chapter 1, Figure 4C,D). In addition, Ogt-cKO mice failed to learn the task 
overall when comparing average errors between the first and last block (Figure 8E).  
During fear conditioning, OGT-cKO mice exhibited elevated baseline freezing 
levels, consistent with the reduction in overall movement without increased anxiety that 
was observed during open field analyses (Figure 8B,F). When controlling for baseline 
freezing, Ogt-cKO mice displayed decreased freezing during contextual testing 
compared to controls, indicative of impairments in hippocampal dependent memory also 
observed in aging mice (Figure 8F; Chapter 1, Figure 4G). While not classically 
associated with aging, Ogt-cKO mice displayed impairments in amygdala-dependent 
cued fear memory as well, indicated by decreased freezing during cued testing (Figure 
8F). These behavioral data demonstrate that Ogt and O-GlcNAc are necessary for 
maintaining hippocampal-dependent spatial and contextual learning and memory in 
young adult mice, and that their conditional loss elicits phenotypes that are reminiscent of 
hippocampal cognitive aging.  
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Discussion 
In this study a novel investigation is performed of the role of O-GlcNAc in regulating adult 
excitatory neuronal function and cognition in the hippocampus. A cell-type specific and 
temporally controlled genetic mouse model (Ogt-cKO) is employed to mimic the age-
related decline in hippocampal Ogt and O-GlcNAcylation, specifically in neurons where 
Ogt and O-GlcNAc are highly expressed [4]. A surprising number of aging-associated 
impairments were identified that are mediated by acute reduction of neuronal O-
GlcNAcylation, including plasticity-related molecular impairments, decreased synaptic 
density, altered synaptic protein composition, and impaired spatial and contextual 
memory. These results reinforce the notion that alterations in neuronal function may lie at 
the heart of age-related cognitive decline, and propose changes in O-GlcNAcylation as a 
driver of synaptic and cognitive impairments in the aging brain.  
O-GlcNAcylation has been linked to neurodegenerative conditions like 
Alzheimer’s disease [21], yet has not been attributed a role in regulating physiological 
aging until now. Furthermore, contradictory reports indicate that constitutive loss of Ogt 
in post-natal excitatory neurons elicits widespread neurodegeneration in the adult brain 
[4], while acute loss of adult neuronal Ogt does not affect cell death [6]. Here the role of 
Ogt in adult hippocampal neurons is resolved, demonstrating loss of Ogt elicits 
alterations reminiscent of aging-associated impairments in the absence of widespread 
neuronal cell death. Nevertheless, both these results and previous work frame O-
GlcNAc as a neuroprotective molecule, suggesting age-related declines in O-GlcNAc 
may increase the susceptibility of the brain to neurodegenerative conditions.  
Interestingly, some alterations in Ogt-cKO mice not classically associated with 
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aging were observed [22], such as a modest increase in LTP in the hippocampal CA1 
region. While increased LTP is often assumed to be a correlate for cognitive 
enhancement, it has also been reported by independent groups in the presence of 
cognitive impairments, suggesting the relationship between LTP and memory regulation 
is more complex than previously believed [19, 20]. Notwithstanding, a more indicative 
measure of hippocampal function is the result of cognitive testing for spatial and 
contextual memory.  
Impairments were observed in two distinct hippocampal-dependent tasks, 
indicating maintenance of excitatory neuronal Ogt and O-GlcNAc are necessary for 
proper hippocampal cognition. These data support the notion that age-related reduction 
of hippocampal Ogt and O-GlcNAc drive impairments in cognition that are observed 
during aging. The impairments we observed in movement, baseline, and cued freezing 
behavior in Ogt-cKO mice are likely due to the fact the CamK2a gene is driving Cre 
expression in additional forebrain regions that govern such behaviors, including the 
substantia nigra and amygdala [3]. While impaired movement and cued freezing 
behavior are not observed in normal aging mice, it is not clear how Ogt and O-GlcNAc 
change in these brain regions with age. These behavioral results, alongside reports in 
the hypothalamus [6], suggest Ogt and O-GlcNAc are necessary for excitatory neuronal 
function in several brain regions, and that age-related changes occurring in sensitive 
regions like the hippocampus manifest as cognitive impairments.   
The question remains for future studies as to whether O-GlcNAcylation may be 
targeted to prevent or reverse cognitive decline in the aging brain. Reports exist that 
indicate enhancement of O-GlcNAcylation can rescue impairments in 
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neurodegenerative mouse models [23], though it is not known whether O-GlcNAc can 
promote enhancements outside of neurodegenerative conditions. Taken together, the in 
vivo data included in this study demonstrate that loss of Ogt in excitatory forebrain 
neurons elicits features of neuronal and synaptic aging, and demonstrates that Ogt and 
O-GlcNAc are necessary for maintaining aging-sensitive forms of hippocampal cognition 
in adult mice. These findings suggest that age-dependent alterations in hippocampal O-
GlcNAcylation promote impairments in learning and memory that occur during normal 
aging. 
  
! 93!
Materials and methods 
 
Animal Models. All mouse handling and use was in accordance with institutional and 
ethical guidelines approved by the University of California San Francisco IACUC. The 
following mouse lines were used: C57BL/6 young mice (The Jackson Laboratory), 
C57BL/6 young and aged mice (National Institutes of Aging; Taconic Biosciences), 
OGTfloxed (The Jackson Laboratory line 004860) CamK2a-CreERT2 (The Jackson 
Laboratory line 012362). All studies were done in male mice. The numbers of mice used 
to result in statistically significant differences were calculated using standard power 
calculations with α = 0.05 and a power of 0.8. We used an online tool 
(http://www.stat.uiowa.edu/~rlenth/Power/index.html) to calculate power and samples 
size based on experience with the respective tests, variability of the assays and inter-
individual differences within groups. Mice were housed under specific pathogen-free 
conditions under a 12 h light-dark cycle. All experiments were randomized and blinded 
by an independent researcher. Researchers remained blinded throughout histological, 
molecular, and behavioral assessments. Groups were un-blinded at the end of each 
experiment upon statistical analysis. 
 
Tamoxifen injections. Animals were injected via intraperitoneal injection with 
180mg/kg of tamoxifen or vehicle once every 24 hours for a total of 5 injections per 
animal. Animals were monitored after recovery and five weeks were allowed to pass 
after the final injection before any analyses were performed.  
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Nissl Staining. Sections were cut to 40µm and mounted on superfrost plus microscope 
slides (ThermoFisher) and allowed to dry overnight. Slides were then soaked in 100% 
ethanol 3x2min each, and then immersed in cresyl violet working solution for 10 min. 
Slides were then dipped in 95% ethanol, soaked in 100% ethanol 2x2min, then in 
Citrasolv 2x2min before being cover slipped with Entellan. Mean intensity was 
quantified using FIJI software (Version 1.0). 
 
Immunohistochemistry. Tissue processing and immunohistochemistry was performed 
on free-floating sections following standard published techniques [24]. Mice were 
anesthetized with ketamine, transcardially perfused with 0.9% saline, and brains 
removed and fixed in phosphate-buffered 4% paraformaldehyde for 48h before 
cryoprotection with 30% sucrose. Free floating coronal sections (40 µm) were incubated 
overnight with either rabbit anti-Cleaved Caspase-3 (Asp175) antibody #9661 (1:400; 
CS Technology) or rabbit anti-c-Fos (Ab-5) (4-17) (1:10,000; Calbiochem) primary 
antibodies, and staining was revealed using biotinylated secondary antibodies and the 
ABC kit (Vector) with Diaminobenzidine (DAB, Sigma-Aldrich). Sections were mounted 
in phosphate buffer on superfrost plus microscope slides (ThermoFisher), allowed to dry 
overnight, briefly soaked in Citrasolv and cover slipped with Entellan. Individual cell 
number was quantified for c-Fos or cleaved caspase 3 using FIJI software (Version 1.0). 
 
Golgi Staining. After brain removal, hemispheres were immersed in 10 ml of A+B 
solution from FD Rapid GolgiStain™ Kit, which was prepared 24 hours prior. Solution 
was then changed after the initial 12 hours, and left for 10 days at room temperature in 
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the dark. Brains were then transferred to solution C, which was changed after the initial 
24 hours, and then left for 3 days at room temperature in the dark. Brains were cut into 
100 µm sections using a vibratome and were mounted onto slides coated with 0.3% 
gelatin in solution C. Slides were then air-dried for 24 hours in the dark. Slides were 
immersed into Milli-Q H2O, 2 x 4 min with gentle shaking, then transferred to a 
developing solution (Solution D, E, and Milli-Q H2O) for 10 min. Slides were then rinsed 
2x4 min in Milli-Q H2O, dehydrated through graded ethanol, immersed in Xylenes 3x4 
min, and then coverslipped using Permount. All slides were then blinded and neurons 
imaged using a 63X oil immersion objective. Tertiary dendritic spine density was 
quantified using FIJI software (Version 1.0) for dendritic tracing and spine count, and 
results were un-blinded just prior to statistical analyses.  
 
Western Blot Analysis. Mouse brain tissues were dissected after perfusion of animal 
and snap frozen and lysed in RIPA lysis buffer (500 mM Tris, pH 7.4, 150 mM NaCl, 
0.5% Na deoxycholate, 1% NP40, 0.1% SDS, complete protease inhibitors 2X; Roche, 
and PUGNAc 100uM; Sigma). Tissue lysates were mixed with 4x NuPage LDS loading 
buffer (Invitrogen), loaded on a 4-12% SDS polyacrylamide gradient gel (Invitrogen), 
and subsequently transferred onto a nitrocellulose membrane. The blots were blocked 
in 5% milk in Tris-Buffered Saline with Tween (TBST) and incubated with mouse anti-O-
GlcNAc antibody (CTD110.6) sc-59623 (1:500, SC Biotech), rabbit anti-OGT antibody 
(H-300) sc-32921 (1:1000, SC Biotech), rabbit anti-PSD-95 antibody #2507 (1:300; CS 
Technology), rabbit anti-NR2B ab65783 (1:1000, Abcam), rabbit anti-synapsin-1 
ab18814 (1:1000, Abcam), mouse anti-synaptophysin (SY38) MAB5258 (1:1000, EMD 
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Millipore), mouse anti-GAPDH (6C5) ab8245 (1:10,000, Abcam), and mouse anti-β-
tubulin (TUJ1) 801201 (1:1000, BioLegend). For cell culture experiments, cells were 
gently washed 2x with cold PBS and then lysed directly in RIPA lysis buffer. 
Horseradish peroxidase-conjugated secondary antibodies and an ECL kit (GE 
Healthcare/Amersham Pharmacia Biotech) were used to detect protein signals. Multiple 
exposures were taken to select images within the dynamic range of the film (GE 
Healthcare Amersham HyperfilmTM ECL). Selected films were scanned (300 dpi) and 
quantified using FIJI software (Version 1.0). GAPDH or β-tubulin bands were used for 
normalization. 
 
Slice Electrophysiology. Coronal brain slices (300 µm) containing hippocampus were 
prepared from 8-10 week old WT and OGT cKO littermate mice. Mice were 
anesthetized with isoflurane, decapitated, and the brain was quickly removed and 
transferred to ice-cold artificial cerebrospinal fluid (ACSF) containing 125 mM NaCl, 2.5 
mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 15 mM glucose, 2 mM CaCl2, and 1 
mM MgCl2, oxygenated with 95% O2 and 5% CO2 (300-305 mOsm, pH 7.4). Acute 
brain slices containing hippocampus were cut with a vibratome (VT1200S, Leica) and 
transferred to an incubation chamber containing ACSF at 34 °C for 30 min and then to a 
recovery chamber containing ACSF at room temperature for 30 min. Before recording, 
coronal slices were hemisected and hippocampi dissected before being transferred to a 
submerged recording chamber perfused with ACSF at a rate of 2~3 ml/min at 30 °C. 
Brain slices were recorded within 4 hours after recovery. CA1 field potential were 
evoked by Schaffer collateral electrical stimulation, recorded using broken tip 
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borosilicate glass pipettes filled with ACSF. Signals were acquired using a Multiclamp 
700B, filtered at 2kHz, and digitized at 10 kHz. After recording a stable baseline for at 
least 20 min, LTP was induced by 20 hz presentation of 4 trains (each consisting of 10 
pulses at 100 hz), and LTD by a single-pulse, low-frequency stimulation (SP-LFS) (900 
pulses at 1 hz). Recorded data were monitored online using WinLTP and WinWCP and 
analyzed offline using MATLAB and Prism. 
 
Radial Arm Water Maze. Paradigm followed previously described protocol [25]. The 
goal arm location containing a platform remains constant throughout the training and 
testing phase, while the start arm is changed during each trial. Entry into an incorrect 
arm is scored as an error, and errors are averaged over training blocks (three 
consecutive trials). On day one during the training phase, mice are trained for 15 trials, 
with trials alternating between a visible and hidden platform. Every 3 trials are counted 
as one block of training. Prior to the final 3 trials of day 1 (block 5), the mice are given 
an extended break, and short-term memory is then tested using three consecutive 
hidden platform trials. On subsequent days during the testing phase, mice are tested for 
15 trials per day with a hidden platform. All behavior is performed double blinded.  
 
Contextual Fear Conditioning. Paradigm follows previously published techniques [26]. 
Mice learned to associate the environmental context (fear conditioning chamber) with an 
aversive stimulus (mild foot shock; unconditioned stimulus, US) enabling testing for 
hippocampal-dependent contextual fear conditioning. The mild foot shock was paired 
with a light and tone cue (conditioned stimulus, CS) in order to also assess amygdala- 
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dependent cued fear conditioning. Conditioned fear was displayed as freezing behavior. 
Specific training parameters are as follows: tone duration is 30 seconds; level is 70 dB, 
2 kHz; shock duration is 2 seconds; intensity is 0.6 mA. On day 1 each mouse was 
placed in a fear-conditioning chamber and allowed to explore for 2 minutes before 
delivery of a 30-second tone (70 dB) ending with a 2-second foot shock (0.6mA). Two 
minutes later, a second CS-US pair was delivered. On day 2 each mouse was first 
place in the fear- conditioning chamber containing the same exact context, but with no 
administration of a CS or foot shock. Freezing was analyzed for 1-3 minutes. One hour 
later, the mice were placed in a new context containing a different odor, cleaning 
solution, floor texture, chamber walls and shape. Animals were allowed to explore for 2 
minutes before being re-exposed to the CS. Freezing was analyzed for 1-3 minutes. 
Freezing was measured using a FreezeScan video tracking system and software 
(Cleversys, Inc). All behavior is performed double blinded.  
 
Data and statistical analysis. Graphed data are expressed as mean ± SEM. Statistical 
analysis was performed with Prism 5.0 software (GraphPad Software). Means between 
two groups were compared with two-tailed, unpaired Student’s t-test. Comparisons of 
means from multiple groups with each other or against one control group were analyzed 
with 2-way ANOVA and Bonferroni post hoc tests. All histology, electrophysiology and 
behavior experiments conducted were done in a randomized and blinded fashion. For 
each experiment, the overall size of the experimental groups corresponded to distinct 
animals. Unique samples were not measured repeatedly within the same 
characterization of a given cohort.  
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Abstract 
Impairments in learning and memory that occur during aging are becoming an increasing 
concern, given that the aging population is expanding rapidly. The scientific community 
has recently demonstrated it is possible to slow, or even reverse certain aspects of brain 
aging – a phenomenon known as rejuvenation. There is a demand for mechanistic 
insights into processes that govern aging and rejuvenation, which hold significant 
translational potential for increasing quality of life in the elderly and aging populations. 
The dynamic post-translational modification O-GlcNAc is a regulator of learning and 
memory, and declines with age in brain regions associated with cognitive impairments 
like the hippocampus. In this study, O-GlcNAc levels are increased in the brains of adult 
and aging mice using viral and pharmacologically-mediated approaches, and the effects 
on learning and memory are assessed. The findings indicate increased O-GlcNAcylation 
is associated with enhanced hippocampal-dependent learning and memory in young 
mice, with a mild beneficial effect observed in aged mice. These results suggest O-
GlcNAc is capable of promoting cognitive enhancements in the adult hippocampus, 
although more extensive investigation is required to determine whether O-GlcNAcylation 
can be employed to promote rejuvenation.  
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Introduction 
Aging steadily drives cognitive impairments and remains the single most dominant risk 
factor for dementia-related neurodegenerative diseases, such as Alzheimer’s disease 
(AD) [1-3]. When considering the rate at which the human population is aging, it 
becomes imperative to identify means by which to maintain cognitive integrity by 
counteracting or reversing the effects of aging, through a process known as 
rejuvenation.  
Previous work using systemic interventions like exercise [4], caloric restriction [5, 
6], and exposure to young blood by parabiosis and plasma treatments [7, 8], have 
demonstrated aspects of brain rejuvenation in rodents. Although these interventions 
demonstrate potential, such demanding alterations in lifestyle are not feasible on a 
global level in elderly humans. Therefore, elucidating the cellular mechanisms that can 
promote rejuvenation is vital for expanding the translational potential of the field of brain 
rejuvenation. Indeed, some mechanistic insight has been gained thus far, particularly in 
aging-sensitive brain regions like the hippocampus (See Chapter 1 for a summary of 
hippocampal aging). Upon exposure to young blood, aged mice experience a 
restoration of phosphorylation at Ser133 on the transcription factor Creb, which is 
known to promote neuronal synaptic plasticity, learning, and memory [9]. During caloric 
restriction, widespread alterations occur in many forms, including alterations in the 
insulin signaling pathway, and inhibition of mTOR signaling [5]. There is also a well 
characterized connection between exercise, cognitive enhancement, and BDNF 
expression in the adult and aging hippocampus [4].  
As an additional approach for rejuvenation, factors that change with age in the 
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hippocampus have been characterized, and subsequently manipulated for more 
mechanistically targeted studies. Despite widespread changes occurring with age, only a 
handful of factors including Dnmt3a2, Rbap48, Creb, and NR2B have been able to rescue 
cognitive impairments when their expression is restored in aged mice [7, 10-13]. Despite 
these findings, the field of rejuvenation is still very much in its early pioneering phase. 
Significant mechanistic insight is still needed, highlighting the urgency for identifying novel 
factors that may serve as targets for future cognitive rejuvenation studies.  
 O-GlcNAcylation declines with age in the hippocampus, a brain region that 
displays numerous stereotypic impairments and cognitive deficits during aging (Chapter 
3, Figure 1A,B; Chapter 1). Reduction of hippocampal neuronal O-GlcNAc recapitulates 
features of cellular and cognitive aging in young adult mice (Chapter 3), demonstrating 
that O-GlcNAc is necessary to maintain integrity in the young adult hippocampus, and 
proposing O-GlcNAc as a functional driver of age-related impairments. Furthermore, in 
the context of neurodegeneration, O-GlcNAc has been proposed as a neuroprotective 
molecule [14]. Protein O-GlcNAcylation is lower in the brains of AD patients [15], as well 
as in animal models of AD and related disorders. Furthermore, loss of neuronal O-
GlcNAc elicits Tau hyperphosphorylation in adult mice [16, 17]. Pharmacologically-
mediated inhibition of Oga, the enzyme that removes O-GlcNAc from proteins, 
increases brain O-GlcNAcylation and rescues cognitive and synaptic impairments in a 
mouse model of AD [18]. Given that aging is the number one risk factor for 
neurodegenerative diseases like AD, changes in O-GlcNAcylation could reside at the 
interface between aging and disease, representing a mechanism by which aging 
promotes impairments and susceptibility to the onset of neurodegeneration. Thus, the 
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question was raised as to whether increasing O-GlcNAcylation could have a beneficial 
impact on cognitive function not only in the context of disease, but in adult and aging 
wild type mice.  
 
Results 
 
Increased O-GlcNAcylation in the adult hippocampus enhances cognitive function 
To test this possibility, an in vivo viral-mediated RNA interference approach was 
employed to knock down expression of the enzyme that removes O-GlcNAc from 
proteins, O-GlcNAcase (Oga). A lentivirus construct was generated encoding either an 
shRNA targeting Oga (sh-Oga), or a scrambled shRNA sequence as a control 
(Scramble), with GFP included as a reporter to mark transfected or infected cells 
(Figure 1A). The lentiviral constructs were initially tested by transfection of a mouse 
Neuro2A cell line (Figure 1B), which had been confirmed to express Oga and O-
GlcNAcylated proteins. Western blot analysis of whole cell lysates taken 48 hours post-
transfection revealed reduction of Oga protein as well as an increase in global protein 
O-GlcNAcylation in sh-Oga transfected cells when compared to Scramble controls  
(Figure 1C,D).  
Infectious lentiviral particles were then generated, and titered to a concentration 
of 109 particles per ml. Using stereotactic (STX) surgery, infectious lentiviral particles 
were delivered directly into the hippocampi of young adult wild type mice (Figure 2A). 
Oga knockdown was confirmed by western blot analysis in lysates of GFP+ sub-
dissected hippocampal tissue, 4 weeks post-injection (Figure 2B,C).  
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Figure 1. Generation of a lentiviral construct targeting Oga. (A) Schematic depiction 
of a lentiviral backbone encoding Scramble (control) or sh-Oga (shRNA targeting mouse 
Oga) sequences, driven by the H1 promoter. The construct also encodes GFP, driven 
by the CMV promoter. (B) Representative field of mouse Neuro2A cells transfected by 
the lentiviral construct. Scale bar = 25µm. (C) Western blot analysis of whole cell 
lysates from Neuro2A cells transfected with either Scramble or sh-Oga, harvested 48 
hours post-transfection. (D) Quantification of (C) normalized to β-Tubulin and 
represented as fold change from Scramble. n = 3 transfected wells per group. Data 
represented as mean ± SEM *P<0.05; t-test.   
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Figure 2. In vivo validation of lentiviral construct targeting mouse Oga. (A) 
Schematic depiction of a stereotactic (STX) injection of lentiviral particles into the 
hippocampi of an adult mouse brain. A representative image of a slice from a STX-
injected hippocampus is shown, with GFP+ infected cells shown in green. (B) 
Representative bands from western blot analysis of whole tissue lysates from GFP+ 
hippocampi infected with either Scramble or sh-Oga lentivirus, harvested 4 weeks after 
injection. (C) Quantification of (B) normalized to GAPDH and represented as fold 
change from Scramble. n = 5 per group. Data represented as mean ± SEM *P<0.05; t-
test.   
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A large cohort of adult wild type mice were then given STX injections into the 
hippocampi, of high-titer infectious lentivirus encoding either sh-Oga or Scramble 
sequences (Figure 3A). Following recovery, anxiety and general motor function was 
assessed using the open field behavioral paradigm, and two forms of hippocampal-
dependent memory were tested using the radial arm water maze (RAWM) and fear 
conditioning paradigms (Figure 3A). As expected, no difference was observed between 
groups in time spent in the periphery or center, basic and fine movements, or rearing 
behavior in the open field task (Figure 3B). This result is indicative of no change in 
anxiety or motor function as a function of Oga knockdown in the hippocampus. All mice 
showed similar learning capacity during the training phase of the RAWM (Figure 3C), 
but Oga knockdown resulted in fewer errors in locating the target platform during short-
term memory testing (Figure 3D). Additionally, long-term memory and overall learning 
were slightly enhanced in mice with knockdown of hippocampal Oga (Figure 3C,E). 
During fear conditioning training, as expected no differences in baseline freezing time 
were detected between groups (Figure 3F). However, mice injected with sh-Oga virus 
exhibited increased freezing time during contextual memory testing, indicative of 
enhanced hippocampal-dependent memory (Figure 3F). As expected, given the viral 
manipulation was specific to the hippocampus, no difference was observed between 
groups during cued memory testing- which is more dependent on the amygdala region 
of the brain (Figure 3F), Collectively, these behavioral data and findings that loss of O-
GlcNAc elicits cognitive impairments (Chapter 3, Figure 7), indicate that modulation of 
O-GlcNAc can bi-directionally regulate hippocampal–dependent cognitive function. O-
GlcNAcylation is therefore considered as molecular target for investigating the reversal 
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Figure 3. sh-Oga injected mice display enhanced spatial and contextual 
hippocampal memory.  
(A) Learning and memory testing in adult mice with increased level of O-GlcNAcylation 
in the hippocampus. Schematic depicting the generation of Scramble and sh-Oga mice 
and subsequent cognitive testing using open field, radial arm water maze (RAWM), and 
fear conditioning behavioral paradigms. (B) Data from the open field paradigm depicting 
percent time spend in periphery and center of the field, as well as basic movements, 
fine movements, and time rearing of Scramble and sh-Oga injected mice. Data shown 
are cumulative from ten minutes of testing, measured using the MotorMonitor software. 
(C-E) Hippocampal-dependent spatial learning and memory was assessed using 
RAWM. Quantification of the number of entry errors during RAWM training and testing 
(C), short-term memory testing (D) and long-term learning and memory testing (E). (F) 
Baseline, contextual, and cued fear memory was assessed using fear conditioning. 
Baseline freezing was measured during the first two minutes of training. Freezing in 
contextual and cued conditions was measured 24 hours after training. n = 12-24 mice 
per group. Data represented as mean ± SEM; *P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001; repeated measures ANOVA, column factor (C); t-test (B-F).  
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of aging-associated cognitive impairments.   
 
Investigating the potential for neuronal O-GlcNAc in restoring cognitive capacity 
in the aged brain 
Given that increasing O-GlcNAcylation in the young hippocampus can improve cognitive 
function, the question was raised as to whether increasing O-GlcNAc in the aged brain 
could rescue cognitive deficits. As an initial approach, and to gain cell-type specificity for 
the role of O-GlcNAc in regulating neuronal aging, lentiviral constructs were generated 
encoding a Synapsin promoter to drive gene over expression (OE) specifically in neurons. 
A construct expressing the mouse Ogt gene was generated, as well as a construct 
expressing GFP alone (Figure 4A). Due to the size of the Ogt gene, a plasmid containing 
both Ogt and GFP yielded a poor lentiviral titer, so a construct without GFP was used. 
Primary neurons isolated from E16.5 embryos were grown and subsequently infected 
with lentiviral particles containing either Synapsin-GFP or Synapsin-Ogt-OE constructs 
(Figure 4B). Western blot of whole neuronal cell lysates confirmed overexpression of the 
Ogt protein in vitro  (Figure 4C).  
Aged wild type mice (17 months old) were then injected with high-titer lentiviral 
particles, directly into their hippocampi using STX surgery (Figure 5A). In order to label 
the injected regions of the hippocampus in Synapsin-Ogt-OE mice, infectious particles 
containing the Synapsin-Ogt-OE construct were mixed with a small aliquot containing 
control particles expressing GFP prior to injection. Mice were then bilaterally injected with 
either Synapsin-GFP (Control) or Synapsin-Ogt-OE + Synapsin-GFP (Ogt-OE), and were 
allowed to age and recover for a further 2 months post-surgery. Brains were sectioned to 
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Figure 4. Generation of neuronal-specific lentiviral Ogt overexpression construct. 
(A) Schematic depiction of lentiviral constructs encoding GFP or Ogt for overexpression 
(OE) driven by the Synapsin promoter. (B) Representative field of primary mouse 
neurons infected by the Synapsin-GFP lentiviral construct. Scale bar = 25µm. (C) 
Representative bands from western blot analysis of whole cell lysates from infected 
neurons showing increased Ogt protein expression, with GAPDH as a loading control.   
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Figure 5. In vivo validation of stereotaxic injection of the Ogt-OE construct into the 
aged hippocampus. (A) Schematic depiction of stereotaxic (STX) injections into the 
mouse hippocampus. (B) Aged mice (17 months old) were injected with either control 
(Syn-GFP) or Ogt-OE (Syn-Ogt-OE + Syn-GFP) lentiviral constructs. Representative 
fluorescent images of GFP+ hippocampi taken following STX surgery confirm the 
injection site is accurate. Scale bar = 200µm (C) Representative bands from western 
blot analysis of lysates from GFP+ infected hippocampal tissue. (D) Representative field 
of Cresyl violet staining for Nissl bodies in control and Ogt-OE mice. Scale bar = 
200µm. (E) Quantification of Nissl mean intensity in neuronal sub-regions. (F) 
Representative field of immunohistological staining for pCreb in control and Ogt-OE 
mice. Scale bar = 200µm. (G) Quantification of pCreb mean intensity in neuronal sub-
regions. n = 7 per group; t-test.   
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confirm GFP+ tissue was found in the hippocampal region (Figure 5B) and GFP+ tissue 
lysate was profiled by western blot to confirm Ogt overexpression (Figure 5C). A cresyl 
violet stain for Nissl bodies confirmed there were no gross changes in hippocampal 
architecture or neuronal cell loss in Control versus Ogt-OE mice (Figure 5D,E). To 
investigate whether overexpression of Ogt may have restored molecular hallmarks of 
aging, hippocampal tissue from Control and Ogt-OE mice was profiled for pCreb 
expression, which declines with age in hippocampal neurons (Chapter 1, Figure 2C,D). 
Ogt-OE mice did not display increased pCreb in the hippocampus when compared to 
Control mice (Figure 5F,G). 
Cognitive function of control and Ogt-OE mice was also assessed, using the open 
field paradigm to measure anxiety and motor function, and the RAWM to measure 
hippocampal-dependent learning and memory (Figure 6A). No difference was observed in 
time spent in the periphery versus center, or in basic and fine movements was between 
groups, indicative of no increased anxiety or impairments in motor function (Figure 6B). In 
RAWM testing, aside from one point of separation during the learning phase, there were 
no significant enhancements in short or long-term spatial memory, or overall learning 
ability in Ogt-OE versus Control mice (Figure 6C,D). Collectively, these data indicate that 
overexpression of Ogt in 17 month old mouse hippocampal neurons is not sufficient to 
enhance spatial memory in an aged brain.  
 
Investigating the potential for Oga inhibitors to rescue cognitive decline under 
normal aging conditions. 
An additional approach was employed to increase brain O-GlcNAcylation, by using a  
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Figure 6. Ogt-OE does not sufficiently enhance cognitive function in aged mice.  
(A) Learning and memory testing in aged mice with increased level of O-GlcNAcylation 
in the hippocampus. Schematic depicting generation of Control and Ogt-OE mice and 
subsequent cognitive testing using open field and radial arm water maze (RAWM). (B) 
Data from the open field paradigm depicting percent time spend in periphery and center 
of the field, as well as basic and fine movements. Data shown are cumulative from ten 
minutes of testing, measured using the MotorMonitor software. (C,D) Hippocampal-
dependent spatial learning and memory was assessed using RAWM. Quantification of 
the number of entry errors during RAWM training and testing  were assessed in (C), and 
overall memory assessed in (D). n = 10-12 mice per group. Data represented as mean 
± SEM; *P<0.05; **P<0.01; ****P<0.0001; repeated measures ANOVA (C); t-test (B,D).  
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selective Oga inhibitor called Thiamet G (THG). THG has previously been shown to 
robustly increase brain O-GlcNAcylation in mice, and rescue cognitive deficits in 
neurodegenerative mouse models of disease [18]. Aged mice (18 month old) were 
injected with either vehicle (Saline) or THG (500mg/kg) every other day for one month, 
followed by RAWM testing to assess spatial learning and memory (Figure 7A). THG 
treatment did not elicit differences in learning or short term memory, but during the long-
term testing phase there was a separation between the two treatment groups as a whole 
(Figure 7B). Additionally, there was a slight advantage in overall learning observed in 
THG-injected mice (Figure 7C). Overall, THG treatment had a very mild but beneficial 
effect on spatial memory in aged mice.  
 
Discussion  
In this study, the role of O-GlcNAcylation was investigated as a regulator of cognitive 
enhancements, in both the adult and aging brain. An in vivo viral-mediated RNAi 
approach was employed to inhibit Oga expression in the adult mouse hippocampus, 
demonstrating that increased O-GlcNAcylation is sufficient to enhance cognitive 
function, even in the young adult hippocampus. This result is exciting, given it 
demonstrates O-GlcNAc is capable of eliciting enhancements even in the absence of 
impairments or disease.  
As an extension of this experiment, O-GlcNAcylation was enhanced in the brains 
of aged mice, both on a cell-type and region-specific level, as well as globally. 
Overexpression of Ogt in aged hippocampal neurons did not elicit any notable changes, 
either at the molecular level by Creb phosphorylation, or at the cognitive level using  
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Figure 7. THG treatment produces a mild beneficial effect on spatial memory in 
aged mice. 
(A) Learning and memory testing in aged mice treated with vehicle or Thiamet-G (THG). 
Schematic depicting intraperitoneal injections in aged mice and subsequent cognitive 
testing using radial arm water maze (RAWM). (B,C) Hippocampal-dependent spatial 
learning and memory was assessed using RAWM. Quantification of the number of entry 
errors during RAWM training and testing  were assessed in (B), and overall memory 
assessed in (C). n = 11-14 mice per group. Data represented as mean ± SEM; *P<0.05; 
repeated measures ANOVA column factor (B); t-test (C).  
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RAWM testing. In a secondary approach, systemic treatment with a selective Oga 
inhibitor, THG, produced a mild cognitive improvement in aged mice. In summary, loss 
of O-GlcNAcylation drives aging-related cognitive phenotypes in the brain, and 
increased O-GlcNAcylation is beneficial for cognitive function- however it still remains to 
be determined whether restoring O-GlcNAc can rejuvenate the aged brain and 
ameliorate cognitive impairments (Figure 8).  
In order to further investigate a role for O-GlcNAc in cognitive rejuvenation during 
aging, these experiments should be repeated with some notable alterations. The viral-
mediated approach of Ogt overexpression should likely be initiated closer to the 
equivalent of middle age (12 months old) and the mice left until 18-20 months before 
cognitive testing. An additional approach could be to employ injections of sh-Oga in 
middle aged or aged mice as well. Regarding pharmacological manipulations, the 
duration and route of administration could be altered in order to investigate more brain-
specific effects. Osmotic mini-pumps for delivery of THG directly in to the brain have 
been piloted in-house with success, and could provide proof-of-principle that increasing 
O-GlcNAcylation is sufficient to restore cognitive decline in the aged brain. Collectively, 
these in vivo data do raise significant translational potential, highlighting O-
GlcNAcylation as a molecular target for eliciting cognitive enhancements, which 
warrants further pursuit in the context of aging.  
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Figure 8. Working model for the role of O-GlcNAcylation in regulating age-related 
cognitive function. 
Model depicting that loss of O-GlcNAc drives impairments in young Ogt-cKO mice and 
aged mice, and increased O-GlcNAc drives enhancements in sh-Oga injected young 
mice. The question still remains as to how O-GlcNAc may be employed to promote 
brain rejuvenation in aged mice.    
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Materials and methods 
 
Animal Models. All mouse handling and use was in accordance with institutional and 
ethical guidelines approved by the University of California San Francisco IACUC. The 
following mouse lines were used: C57BL/6 young mice (The Jackson Laboratory), 
C57BL/6 young and aged mice (National Institutes of Aging; Taconic Biosciences). All 
studies were done in male mice. The numbers of mice used to result in statistically 
significant differences were calculated using standard power calculations with α = 0.05 
and a power of 0.8. We used an online tool 
(http://www.stat.uiowa.edu/~rlenth/Power/index.html) to calculate power and samples 
size based on experience with the respective tests, variability of the assays and inter-
individual differences within groups. Mice were housed under specific pathogen-free 
conditions under a 12 h light-dark cycle. All experiments were randomized and blinded 
by an independent researcher. Researchers remained blinded throughout histological, 
molecular, and behavioral assessments. Groups were un-blinded at the end of each 
experiment upon statistical analysis. 
 
Radial Arm Water Maze. Paradigm followed previously described protocol [19]. The 
goal arm location containing a platform remains constant throughout the training and 
testing phase, while the start arm is changed during each trial. Entry into an incorrect 
arm is scored as an error, and errors are averaged over training blocks (three 
consecutive trials). On day one during the training phase, mice are trained for 15 trials, 
with trials alternating between a visible and hidden platform. Every 3 trials are counted 
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as one block of training. Prior to the final 3 trials of day 1 (block 5), the mice are given 
an extended break, and short-term memory is then tested using three consecutive 
hidden platform trials. On subsequent days during the testing phase, mice are tested for 
15 trials per day with a hidden platform. All behavior is performed double blinded.  
 
Contextual Fear Conditioning. Paradigm follows previously published techniques [20]. 
Mice learned to associate the environmental context (fear conditioning chamber) with an 
aversive stimulus (mild foot shock; unconditioned stimulus, US) enabling testing for 
hippocampal-dependent contextual fear conditioning. The mild foot shock was paired 
with a light and tone cue (conditioned stimulus, CS) in order to also assess amygdala- 
dependent cued fear conditioning. Conditioned fear was displayed as freezing behavior. 
Specific training parameters are as follows: tone duration is 30 seconds; level is 70 dB, 
2 kHz; shock duration is 2 seconds; intensity is 0.6 mA. On day 1 each mouse was 
placed in a fear-conditioning chamber and allowed to explore for 2 minutes before 
delivery of a 30-second tone (70 dB) ending with a 2-second foot shock (0.6mA). Two 
minutes later, a second CS-US pair was delivered. On day 2 each mouse was first 
place in the fear- conditioning chamber containing the same exact context, but with no 
administration of a CS or foot shock. Freezing was analyzed for 1-3 minutes. One hour 
later, the mice were placed in a new context containing a different odor, cleaning 
solution, floor texture, chamber walls and shape. Animals were allowed to explore for 2 
minutes before being re-exposed to the CS. Freezing was analyzed for 1-3 minutes. 
Freezing was measured using a FreezeScan video tracking system and software 
(Cleversys, Inc). All behavior is performed double blinded.  
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Stereotaxic injections. Animals were placed in a stereotaxic frame and anesthetized 
with 2% isoflurane (2L/min oxygen flow rate) delivered through an anesthesia nose 
cone. Ophthalmic eye ointment was applied to the cornea to prevent desiccation during 
surgery. The area around the incision was trimmed. Viral solutions were injected 
bilaterally into the dorsal hippocampi using the following coordinates: (from bregma) 
anterior = -2mm, lateral = 1.5mm, (from skull surface) height = -2.1mm. 2µl volume was 
injected stereotaxically over 10 minutes (injection speed: 0.20µl/min) using a 10µl 26s 
gauge Hamilton syringe. To limit reflux along the injection track, the needle was 
maintained in situ for three minutes, slowly pulled out half way and kept in position for 
an additional two minutes. The skin was closed using silk suture. Each mouse was 
injected subcutaneously with the analgesic Bupranex. Mice were single-housed and 
monitored during recovery. 
 
Western Blot Analysis. Mouse brain tissues were dissected after perfusion of animal 
and further sub-dissected for GFP+ tissue on a fluorescent dissection microscope. 
Tissue was then snap frozen and lysed in RIPA lysis buffer (500 mM Tris, pH 7.4, 150 
mM NaCl, 0.5% Na deoxycholate, 1% NP40, 0.1% SDS, complete protease inhibitors 
2X; Roche, and PUGNAc 100uM; Sigma). Tissue lysates were mixed with 4x NuPage 
LDS loading buffer (Invitrogen), loaded on a 4-12% SDS polyacrylamide gradient gel 
(Invitrogen), and subsequently transferred onto a nitrocellulose membrane. The blots 
were blocked in 5% milk in Tris-Buffered Saline with Tween (TBST) and incubated with 
mouse anti-O-GlcNAc antibody (CTD110.6) sc-59623 (1:500, SC Biotech), rabbit anti-
OGT antibody (H-300) sc-32921 (1:1000, SC Biotech), rabbit anti-OGA ab124807 
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(1:600, Abcam), mouse anti-GAPDH (6C5) ab8245 (1:10,000, Abcam), and mouse anti-
β-tubulin (TUJ1) 801201 (1:1000, BioLegend). For cell culture experiments, cells were 
gently washed 2x with cold PBS and then lysed directly in RIPA lysis buffer. 
Horseradish peroxidase-conjugated secondary antibodies and an ECL kit (GE 
Healthcare/Amersham Pharmacia Biotech) were used to detect protein signals. Multiple 
exposures were taken to select images within the dynamic range of the film (GE 
Healthcare Amersham HyperfilmTM ECL). Selected films were scanned (300 dpi) and 
quantified using FIJI software (Version 1.0). GAPDH or β-tubulin bands were used for 
normalization. 
 
Thiamet-G injections. Animals were treated via intraperitoneal injection with 500mg/kg 
of Thiamet G (THG) or vehicle (Saline) once every 48 hours for a total of 4 weeks. 
Animals were monitored continuously throughout and were allowed to recover for 3 
days after their last injection before cognitive testing began.  
 
Nissl Staining. Sections were cut to 40µm and mounted on superfrost plus microscope 
slides (ThermoFisher) and allowed to dry overnight. Slides were then soaked in 100% 
ethanol 3x2min each, and then immersed in cresyl violet working solution for 10 min. 
Slides were then dipped in 95% ethanol, soaked in 100% ethanol 2x2min, then in 
Citrasolv 2x2min before being cover slipped with Entellan. Mean intensity was 
quantified using FIJI software (Version 1.0). 
 
Immunohistochemistry. Tissue processing and immunohistochemistry was performed 
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on free-floating sections following standard published techniques [21]. Mice were 
anesthetized with ketamine, transcardially perfused with 0.9% saline, and brains 
removed and fixed in phosphate-buffered 4% paraformaldehyde for 48h before 
cryoprotection with 30% sucrose. Free floating coronal sections (40 µm) were incubated 
overnight with rabbit anti-phospho-Creb (Ser133) (1:2,500; CST) and staining was 
revealed using biotinylated secondary antibodies and the ABC kit (Vector) with 
Diaminobenzidine (DAB, Sigma-Aldrich). Sections were mounted in phosphate buffer on 
superfrost plus microscope slides (ThermoFisher), allowed to dry overnight, briefly 
soaked in Citrasolv and cover slipped with Entellan. Mean intensity was quantified using 
FIJI software (Version 1.0). 
 
Viral plasmids and generation of lentiviral particles. A lentivirus encoding small 
hairpin RNAs (shRNA) targeting endogenous OGA were generated using a lentiviral 
shRNA expression system (pGreenPuro shRNA, System Biosciences) according to the 
manufacturer's instructions. The OGA-targeted [22] and luciferase targeted [23] 
scramble sequences (OGA, 5′-AAGTATACCAAGCCAAATGGT-3′; Scramble, 5′-
GCCATTCTATCCTCTAGAGGA-3′) were cloned into the pGreenPuro vector. In 
addition, overexpression lentivirus encoding a Synapsin promoter to drive expression of 
Ogt (CloneId: 6830845, Thermofisher) or GFP alone (hrGFP) was generated as well. 
Construct quality was tested with Western blot analysis and sequencing. Preparation of 
non-replicative lentiviral particles was performed using the UCSF Viracore, and titered 
to 1.0x109 viral particles/ml.  
Cell culture experiments. An N2A neuronal cell line was used for confirming the 
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effectiveness of the shRNA in vitro. Cells were plated at a confluency of 85-90 percent 
for transfection experiments. Lipofectamine 3000 (Invitrogen) was used as transfection 
reagent. Culture media (DMEM + 10% FBS) was exchanged after 6h to reduce toxicity 
caused by the transfection reagent. Transfection was assessed with the help of GFP 
reporters and fluorescence microscopy. Cells were lysed 48 hours following transfection 
in the same RIPA buffer used for tissue lysis. Experiments were performed in triplicates. 
For validation of infectious lentiviral particles, primary neurons were harvested from the 
brains of E16.5 embryos following the protocol outlined in the Worthington papain 
dissociation system kit (Cat no. LK0003150). Neurons were infected for 48 hours and 
harvested in the same RIPA buffer used for tissue lysis. 
 
Data and statistical analysis. Graphed data are expressed as mean ± SEM. Statistical 
analysis was performed with Prism 5.0 software (GraphPad Software). Means between 
two groups were compared with two-tailed, unpaired Student’s t-test. Comparisons of 
means from multiple groups with each other or against one control group were analyzed 
with 2-way ANOVA and Bonferroni post hoc tests. All histology and behavior 
experiments conducted were done in a randomized and blinded fashion. For each 
experiment, the overall size of the experimental groups corresponded to distinct 
animals. Unique samples were not measured repeatedly within the same 
characterization of a given cohort.  
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